{ "version": "2.2", "instance": { "mpw-20240331.htm": { "nsprefix": "mpw", "nsuri": "http://medicalpropertiestrust.com/20240331", "dts": { "inline": { "local": [ "mpw-20240331.htm" ] }, "schema": { "local": [ "mpw-20240331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/2023/calculation-1.1.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-sub-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] } }, "keyStandard": 212, "keyCustom": 117, "axisStandard": 32, "axisCustom": 0, "memberStandard": 46, "memberCustom": 85, "hidden": { "total": 19, "http://xbrl.sec.gov/dei/2023": 8, "http://fasb.org/us-gaap/2023": 11 }, "contextCount": 375, "entityCount": 1, "segmentCount": 141, "elementCount": 768, "unitCount": 15, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 813, "http://xbrl.sec.gov/dei/2023": 54, "http://xbrl.sec.gov/ecd/2023": 4, "http://fasb.org/srt/2023": 1 }, "report": { "R1": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R2": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets", "longName": "100010 - Statement - Condensed Consolidated Balance Sheets", "shortName": "Condensed Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "C_159e1f14-80ee-4341-af05-6e13aea83582", "name": "mpw:LandBuildingsAndImprovementsIntangibleLeaseAssetsAndOther", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_159e1f14-80ee-4341-af05-6e13aea83582", "name": "mpw:LandBuildingsAndImprovementsIntangibleLeaseAssetsAndOther", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R3": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical", "longName": "100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "C_159e1f14-80ee-4341-af05-6e13aea83582", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_159e1f14-80ee-4341-af05-6e13aea83582", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R4": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited", "longName": "100030 - Statement - Condensed Consolidated Statements of Net Income (Unaudited)", "shortName": "Condensed Consolidated Statements of Net Income (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "mpw:RentBilled", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "mpw:RentBilled", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R5": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveLossIncomeUnaudited", "longName": "100040 - Statement - Condensed Consolidated Statements of Comprehensive (Loss) Income (Unaudited)", "shortName": "Condensed Consolidated Statements of Comprehensive (Loss) Income (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:ProfitLoss", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_5462b5a7-5e12-4231-ba82-d552b95ed38a", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "unique": true } }, "R6": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "longName": "100050 - Statement - Condensed Consolidated Statements of Equity / Capital", "shortName": "Condensed Consolidated Statements of Equity / Capital", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "C_3bc26aef-432c-42f4-b130-079f539d3a64", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_3bc26aef-432c-42f4-b130-079f539d3a64", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R7": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical", "longName": "100060 - Statement - Condensed Consolidated Statements of Equity / Capital (Parenthetical)", "shortName": "Condensed Consolidated Statements of Equity / Capital (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "C_5462b5a7-5e12-4231-ba82-d552b95ed38a", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_b3e99234-ec7b-4aae-9e1d-ccc772140d4d", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "unique": true } }, "R8": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "longName": "100070 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:ProfitLoss", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "unique": true } }, "R9": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:NetIncomeLoss", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true }, "uniqueAnchor": null }, "R10": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R11": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureOrganization", "longName": "995455 - Disclosure - Organization", "shortName": "Organization", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R12": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies", "longName": "995465 - Disclosure - Summary of Significant Accounting Policies", "shortName": "Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R13": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities", "longName": "995475 - Disclosure - Real Estate and Other Activities", "shortName": "Real Estate and Other Activities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:RealEstateDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:RealEstateDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R14": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebt", "longName": "995485 - Disclosure - Debt", "shortName": "Debt", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:LongTermDebtTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:LongTermDebtTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R15": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureIncomeTaxes1", "longName": "995495 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R16": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureStockAwards", "longName": "995505 - Disclosure - Stock Awards", "shortName": "Stock Awards", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R17": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstruments", "longName": "995515 - Disclosure - Fair Value of Financial Instruments", "shortName": "Fair Value of Financial Instruments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R18": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareUnit", "longName": "995525 - Disclosure - Earnings Per Share/Unit", "shortName": "Earnings Per Share/Unit", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R19": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureCommitmentsAndContingencies", "longName": "995535 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R20": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEvents1", "longName": "995545 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R21": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies", "longName": "995555 - Disclosure - Summary of Significant Accounting Policies (Policies)", "shortName": "Summary of Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "21", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:ConsolidationPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:ConsolidationPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R22": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables", "longName": "995565 - Disclosure - Summary of Significant Accounting Policies (Tables)", "shortName": "Summary of Significant Accounting Policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "22", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:ConsolidationVariableInterestEntityPolicy", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:ConsolidationVariableInterestEntityPolicy", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R23": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables", "longName": "995575 - Disclosure - Real Estate and Other Activities (Tables)", "shortName": "Real Estate and Other Activities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "23", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R24": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtTables", "longName": "995585 - Disclosure - Debt (Tables)", "shortName": "Debt (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R25": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsTables", "longName": "995595 - Disclosure - Fair Value of Financial Instruments (Tables)", "shortName": "Fair Value of Financial Instruments (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R26": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareUnitTables", "longName": "995605 - Disclosure - Earnings Per Share/Unit (Tables)", "shortName": "Earnings Per Share/Unit (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R27": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail", "longName": "995615 - Disclosure - Organization - Additional Information (Detail)", "shortName": "Organization - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "27", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "mpw:PercentageOfLeasedAssetsOwned", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "mpw:PercentageOfLeasedAssetsOwned", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R28": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails", "longName": "995625 - Disclosure - Summary of Significant Accounting Policies - Summary of Carrying Value and Classification of the Assets and Maximum Exposure (Details)", "shortName": "Summary of Significant Accounting Policies - Summary of Carrying Value and Classification of the Assets and Maximum Exposure (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "28", "firstAnchor": { "contextRef": "C_89bd99fd-edec-4df7-84fe-82a4cf8bf425", "name": "us-gaap:VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:ConsolidationVariableInterestEntityPolicy", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_89bd99fd-edec-4df7-84fe-82a4cf8bf425", "name": "us-gaap:VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:ConsolidationVariableInterestEntityPolicy", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R29": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "longName": "995635 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)", "shortName": "Summary of Significant Accounting Policies - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "C_159e1f14-80ee-4341-af05-6e13aea83582", "name": "mpw:MinimumPercentageOfReconcilingItemsQuantitativeThresholdOfTheStatutoryTax", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_159e1f14-80ee-4341-af05-6e13aea83582", "name": "mpw:MinimumPercentageOfReconcilingItemsQuantitativeThresholdOfTheStatutoryTax", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R30": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "longName": "995645 - Disclosure - Real Estate and Other Activities - Net Assets Acquired (Detail)", "shortName": "Real Estate and Other Activities - Net Assets Acquired (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "C_159e1f14-80ee-4341-af05-6e13aea83582", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_159e1f14-80ee-4341-af05-6e13aea83582", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "unique": true } }, "R31": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail", "longName": "995655 - Disclosure - Real Estate and Other Activities - Net Assets Acquired (Parenthetical) (Detail)", "shortName": "Real Estate and Other Activities - Net Assets Acquired (Parenthetical) (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "C_f33fa788-68f5-4446-8761-fdeee4c55501", "name": "mpw:BusinessCombinationLoansPaidDownOnAcquisitionLoans", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_4f85ceac-3198-40eb-ac21-300be60ea5e8", "name": "mpw:BusinessCombinationLoansPaidDownOnAcquisitionLoans", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "link:footnote", "div", "div", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "unique": true } }, "R32": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "longName": "995665 - Disclosure - Real Estate and Other Activities - 2023 Activity - Additional Information (Detail)", "shortName": "Real Estate and Other Activities - 2023 Activity - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:ImpairmentOfRealEstate", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_16b92bc7-f947-443f-889a-9a3a436a9933", "name": "mpw:CapitalRestructuringCosts", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "unique": true } }, "R33": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "longName": "995675 - Disclosure - Real Estate and Other Activities - Development Activities - Summary of Status on Current Development Projects (Detail)", "shortName": "Real Estate and Other Activities - Development Activities - Summary of Status on Current Development Projects (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "C_159e1f14-80ee-4341-af05-6e13aea83582", "name": "mpw:DevelopmentProjectsOriginalCommitmentAmount", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "mpw:ScheduleOfDevelopmentProjectsTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_159e1f14-80ee-4341-af05-6e13aea83582", "name": "mpw:DevelopmentProjectsOriginalCommitmentAmount", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "mpw:ScheduleOfDevelopmentProjectsTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R34": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail", "longName": "995685 - Disclosure - Real Estate and Other Activities- Development Activities - Additional Information (Detail)", "shortName": "Real Estate and Other Activities- Development Activities - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "C_302d135a-415f-4567-aee0-81dcff9ca33f", "name": "mpw:NumberOfOtherDevelopmentProjects", "unitRef": "U_Projects", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_302d135a-415f-4567-aee0-81dcff9ca33f", "name": "mpw:NumberOfOtherDevelopmentProjects", "unitRef": "U_Projects", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R35": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2024ActivityAdditionalInformationDetail", "longName": "995695 - Disclosure - Real Estate and Other Activities - Disposals - 2024 Activity Additional Information (Detail)", "shortName": "Real Estate and Other Activities - Disposals - 2024 Activity Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "C_71317e7b-791d-4171-b506-4dc1bdd58415", "name": "mpw:NumberOfPropertiesSold", "unitRef": "U_Property", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_71317e7b-791d-4171-b506-4dc1bdd58415", "name": "mpw:NumberOfPropertiesSold", "unitRef": "U_Property", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R36": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "longName": "995705 - Disclosure - Real Estate and Other Activities - Disposals - 2023 Activity Additional Information (Detail)", "shortName": "Real Estate and Other Activities - Disposals - 2023 Activity Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "C_5462b5a7-5e12-4231-ba82-d552b95ed38a", "name": "mpw:EstimatedFeesToSellTheHospitals", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_5462b5a7-5e12-4231-ba82-d552b95ed38a", "name": "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "unique": true } }, "R37": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesDesignatedAsHeldForSaleAndSoldDetails", "longName": "995715 - Disclosure - Real Estate and Other Activities - Summary of Operating Results from Properties Designated as Held for Sale and Sold (Details)", "shortName": "Real Estate and Other Activities - Summary of Operating Results from Properties Designated as Held for Sale and Sold (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:Revenues", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_14821e92-356f-4507-8bdb-7144308a5eff", "name": "us-gaap:Revenues", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "unique": true } }, "R38": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail", "longName": "995725 - Disclosure - Real Estate and Other Activities - Leasing Operations (Lessor) - Additional Information (Detail)", "shortName": "Real Estate and Other Activities - Leasing Operations (Lessor) - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "C_159e1f14-80ee-4341-af05-6e13aea83582", "name": "us-gaap:LessorOperatingLeaseRenewalTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_159e1f14-80ee-4341-af05-6e13aea83582", "name": "us-gaap:LessorOperatingLeaseRenewalTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R39": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail", "longName": "995735 - Disclosure - Real Estate and Other Activities - Components of Total Investment in Financing Leases (Detail)", "shortName": "Real Estate and Other Activities - Components of Total Investment in Financing Leases (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "C_159e1f14-80ee-4341-af05-6e13aea83582", "name": "us-gaap:DirectFinancingLeaseLeaseReceivable", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_159e1f14-80ee-4341-af05-6e13aea83582", "name": "us-gaap:DirectFinancingLeaseLeaseReceivable", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R40": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetails", "longName": "995745 - Disclosure - Real Estate and Other Activities - Other Leasing Activities - Additional Information (Details)", "shortName": "Real Estate and Other Activities - Other Leasing Activities - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "C_159e1f14-80ee-4341-af05-6e13aea83582", "name": "mpw:PercentageOfVacantOnLeasedProperty", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_159e1f14-80ee-4341-af05-6e13aea83582", "name": "mpw:PercentageOfVacantOnLeasedProperty", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R41": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "longName": "995765 - Disclosure - Real Estate and Other Activities - Pipeline Health System - Additional Information (Detail)", "shortName": "Real Estate and Other Activities - Pipeline Health System - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "C_f47f9527-f43c-47e5-98ec-076d67c50b1f", "name": "us-gaap:DeferredRentReceivablesNet", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_f47f9527-f43c-47e5-98ec-076d67c50b1f", "name": "us-gaap:DeferredRentReceivablesNet", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R42": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "longName": "995775 - Disclosure - Real Estate and Other Activities - Steward Health Care System - Additional Information (Details)", "shortName": "Real Estate and Other Activities - Steward Health Care System - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:ImpairmentOfRealEstate", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_8b167cd2-6b4f-45ac-abdf-0cb926c1e994", "name": "mpw:EquityInvestmentsPercentage", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "unique": true } }, "R43": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "longName": "995795 - Disclosure - Real Estate and Other Activities - Prospect - Additional Information) (Details)", "shortName": "Real Estate and Other Activities - Prospect - Additional Information) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:Revenues", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_68a42a1d-6c06-465a-9d23-b1db48e71f79", "name": "mpw:RentalRevenue", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "unique": true } }, "R44": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherUpdatesAdditionalInformationDetails", "longName": "995805 - Disclosure - Real Estate and Other Activities - Other Updates - Additional Information (Details)", "shortName": "Real Estate and Other Activities - Other Updates - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "C_5462b5a7-5e12-4231-ba82-d552b95ed38a", "name": "mpw:StraightLineRentReceivables", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true }, "uniqueAnchor": null }, "R45": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "longName": "995815 - Disclosure - Real Estate and Other Activities - Investments in Unconsolidated Real Estate Joint Ventures - Additional Information (Details)", "shortName": "Real Estate and Other Activities - Investments in Unconsolidated Real Estate Joint Ventures - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "C_bfb788a5-b48d-4a16-b54b-882b748913b8", "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_bfb788a5-b48d-4a16-b54b-882b748913b8", "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R46": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails", "longName": "995825 - Disclosure - Real Estate and Other Activities - Summary of Investments in Unconsolidated Real Estate Joint Ventures by Operator (Details)", "shortName": "Real Estate and Other Activities - Summary of Investments in Unconsolidated Real Estate Joint Ventures by Operator (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "C_159e1f14-80ee-4341-af05-6e13aea83582", "name": "us-gaap:RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_2171c4d4-324b-4951-88a1-8988c242ad9d", "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "td", "tr", "table", "mpw:SummaryOfInvestmentsInUnconsolidatedOperatingEntitiesTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "unique": true } }, "R47": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "longName": "995835 - Disclosure - Real Estate and Other Activities - Summary of Investments in Unconsolidated Operating Entities (Details)", "shortName": "Real Estate and Other Activities - Summary of Investments in Unconsolidated Operating Entities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "C_159e1f14-80ee-4341-af05-6e13aea83582", "name": "mpw:InvestmentsInUnconsolidatedOperatingEntities", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_42d16af4-c49a-47a2-9df6-6584424bdbd1", "name": "mpw:InvestmentsInUnconsolidatedOperatingEntities", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "unique": true } }, "R48": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail", "longName": "995845 - Disclosure - Real Estate and Other Activities - Investments in Unconsolidated Operating Entities - Additional Information (Detail)", "shortName": "Real Estate and Other Activities - Investments in Unconsolidated Operating Entities - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "C_4eb2b639-7dfa-41e3-b36b-cf3062a4969c", "name": "mpw:UnfavorableFairMarketValueAdjustmentOnInvestment", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_4eb2b639-7dfa-41e3-b36b-cf3062a4969c", "name": "mpw:UnfavorableFairMarketValueAdjustmentOnInvestment", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R49": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail", "longName": "995855 - Disclosure - Real Estate and Other Activities - Other Investment Activities - Additional Information (Detail)", "shortName": "Real Estate and Other Activities - Other Investment Activities - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "C_ad933a25-575e-44ee-a021-38cfde335ec0", "name": "mpw:GainLossOnSaleOfInterestInSyndicatedTermLoan", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_ad933a25-575e-44ee-a021-38cfde335ec0", "name": "mpw:GainLossOnSaleOfInterestInSyndicatedTermLoan", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R50": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfActivityInCreditLossReservesDetails", "longName": "995865 - Disclosure - Real Estate and Other Activities - Summary of Activity in Credit Loss Reserves (Details)", "shortName": "Real Estate and Other Activities - Summary of Activity in Credit Loss Reserves (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "C_73ddc8e6-3ad7-4103-bd56-70daaa62ff97", "name": "us-gaap:FinancingReceivableAllowanceForCreditLosses", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "mpw:SummaryOfCreditLossReservesTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_73ddc8e6-3ad7-4103-bd56-70daaa62ff97", "name": "us-gaap:FinancingReceivableAllowanceForCreditLosses", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "mpw:SummaryOfCreditLossReservesTableTextBlock", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R51": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfActivityInCreditLossReservesParentheticalDetails", "longName": "995875 - Disclosure - Real Estate and Other Activities - Summary of Activity in Credit Loss Reserves (Parenthetical) (Details)", "shortName": "Real Estate and Other Activities - Summary of Activity in Credit Loss Reserves (Parenthetical) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "C_4870d044-8e1a-45d0-bb34-6570a3a5c44c", "name": "mpw:LoanDueFromAffiliates", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true }, "uniqueAnchor": null }, "R52": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "longName": "995895 - Disclosure - Real Estate and Other Activities - Schedule of Concentrations of Credit Risk (Details)", "shortName": "Real Estate and Other Activities - Schedule of Concentrations of Credit Risk (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "C_159e1f14-80ee-4341-af05-6e13aea83582", "name": "us-gaap:Assets", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_6f534ed5-46e1-411e-827c-96a73b5703d8", "name": "us-gaap:Assets", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "unique": true } }, "R53": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails", "longName": "995905 - Disclosure - Real Estate and Other Activities - Schedule of Concentrations of Credit Risk (Parenthetical) (Details)", "shortName": "Real Estate and Other Activities - Schedule of Concentrations of Credit Risk (Parenthetical) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "C_159e1f14-80ee-4341-af05-6e13aea83582", "name": "mpw:InvestmentsInUnconsolidatedOperatingEntities", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_1bdb6ffe-baf0-4ac6-a994-76856e851084", "name": "mpw:InvestmentsInUnconsolidatedOperatingEntities", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "div", "div", "ix:continuation", "div", "us-gaap:RealEstateDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "unique": true } }, "R54": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "longName": "995915 - Disclosure - Debt - Summary of Debt (Detail)", "shortName": "Debt - Summary of Debt (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "C_159e1f14-80ee-4341-af05-6e13aea83582", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_159e1f14-80ee-4341-af05-6e13aea83582", "name": "us-gaap:DeferredFinanceCostsNet", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "unique": true } }, "R55": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail", "longName": "995925 - Disclosure - Debt - Summary of Debt (Parenthetical) (Detail)", "shortName": "Debt - Summary of Debt (Parenthetical) (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "C_159e1f14-80ee-4341-af05-6e13aea83582", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_6382aed1-5b3d-4c45-9e14-1950a3b3a62a", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "U_GBP", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "link:footnote", "div", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "unique": true } }, "R56": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail", "longName": "995935 - Disclosure - Debt - Principal Payments Due for Debt (Detail)", "shortName": "Debt - Principal Payments Due for Debt (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "C_159e1f14-80ee-4341-af05-6e13aea83582", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_159e1f14-80ee-4341-af05-6e13aea83582", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "div", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R57": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtCovenantsAdditionalInformationDetail", "longName": "995965 - Disclosure - Debt - Covenants - Additional Information (Detail)", "shortName": "Debt - Covenants - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "mpw:PercentageOfDividendsPayableOnBasisOfAdjustedOperatingFunds", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "mpw:PercentageOfDividendsPayableOnBasisOfAdjustedOperatingFunds", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R58": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail", "longName": "995975 - Disclosure - Income Taxes - Additional Information (Detail)", "shortName": "Income Taxes - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:IncomeTaxExpenseBenefit", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "mpw:IncomeTaxBenefitRelatedToTheInitialLoanImpairment", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "unique": true } }, "R59": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail", "longName": "995985 - Disclosure - Stock Awards - Additional Information (Detail)", "shortName": "Stock Awards - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:ShareBasedCompensation", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_159e1f14-80ee-4341-af05-6e13aea83582", "name": "mpw:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantWithCashSettlement", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "unique": true } }, "R60": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail", "longName": "995995 - Disclosure - Fair Value of Financial Instruments - Summary of Fair Value Information of Financial Instruments (Detail)", "shortName": "Fair Value of Financial Instruments - Summary of Fair Value Information of Financial Instruments (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "C_159e1f14-80ee-4341-af05-6e13aea83582", "name": "mpw:InterestAndRentReceivable", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_159e1f14-80ee-4341-af05-6e13aea83582", "name": "mpw:Loans", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "unique": true } }, "R61": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "longName": "996005 - Disclosure - Fair Value of Financial Instruments - Summary of Fair Value Information of Financial Instruments (Parenthetical) (Detail)", "shortName": "Fair Value of Financial Instruments - Summary of Fair Value Information of Financial Instruments (Parenthetical) (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "C_159e1f14-80ee-4341-af05-6e13aea83582", "name": "us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_9242ea56-65cb-48ba-adf5-ad645ee6c479", "name": "mpw:InvestmentsInUnconsolidatedOperatingEntities", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "div", "div", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "unique": true } }, "R62": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "longName": "996015 - Disclosure - Fair Value of Financial Instruments - Additional Information (Detail)", "shortName": "Fair Value of Financial Instruments - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "C_5c36c50a-5d33-41dc-8fdd-9b769b8fb727", "name": "mpw:FairValueMeasurementDiscountRate", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_5c36c50a-5d33-41dc-8fdd-9b769b8fb727", "name": "mpw:FairValueMeasurementDiscountRate", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R63": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "longName": "996025 - Disclosure - Fair Value of Financial Instruments - Equity Interest in Related Party and Related Loans Measured at Fair Value on Recurring Basis (Detail)", "shortName": "Fair Value of Financial Instruments - Equity Interest in Related Party and Related Loans Measured at Fair Value on Recurring Basis (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "C_3d83075a-96aa-4fbb-b438-fb5a6d37704a", "name": "us-gaap:InvestmentOwnedAtFairValue", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_3d83075a-96aa-4fbb-b438-fb5a6d37704a", "name": "us-gaap:InvestmentOwnedAtFairValue", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R64": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDlomBySensitivityAnalysisByUsingBasisPointVariationsDetails", "longName": "996035 - Disclosure - Fair Value of Financial Instruments - Schedule of Effects of Movement in DLOM by Sensitivity Analysis by Using Basis Point Variations (Details)", "shortName": "Fair Value of Financial Instruments - Schedule of Effects of Movement in DLOM by Sensitivity Analysis by Using Basis Point Variations (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "C_1b59d45f-7fe8-435e-b382-69bdf38872db", "name": "us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfSensitivityAnalysisOfFairValueOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_1b59d45f-7fe8-435e-b382-69bdf38872db", "name": "us-gaap:InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfSensitivityAnalysisOfFairValueOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock", "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R65": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "longName": "996045 - Disclosure - Earnings Per Share/Unit - Calculation of Earnings Per Share (Detail)", "shortName": "Earnings Per Share/Unit - Calculation of Earnings Per Share (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "us-gaap:ProfitLoss", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_76657b52-c293-4817-bf15-5a6e59e1909c", "name": "mpw:UndistributedEarningAllocatedToParticipatingSecurities", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "unique": true } }, "R66": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "longName": "996055 - Disclosure - Commitments and Contingencies - Additional Information (Detail)", "shortName": "Commitments and Contingencies - Additional Information (Detail)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "C_888f8c6b-feac-4a28-82cc-ff713b3d290c", "name": "mpw:DebtorInPossessionFinancingToAffiliateFundsProvided", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_888f8c6b-feac-4a28-82cc-ff713b3d290c", "name": "mpw:DebtorInPossessionFinancingToAffiliateFundsProvided", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } }, "R67": { "role": "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "longName": "996065 - Disclosure - Subsequent Events - Additional Information (Details)", "shortName": "Subsequent Events - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "C_0656e877-9b2a-4d12-8327-32d4ef5dd405", "name": "us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-8", "ancestors": [ "span", "p", "us-gaap:SubsequentEventsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_0656e877-9b2a-4d12-8327-32d4ef5dd405", "name": "us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-8", "ancestors": [ "span", "p", "us-gaap:SubsequentEventsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mpw-20240331.htm", "first": true, "unique": true } } }, "tag": { "country_AU": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "AU", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail" ], "lang": { "en-us": { "role": { "label": "AUSTRALIA", "terseLabel": "Australia [Member]" } } }, "auth_ref": [] }, "stpr_AZ": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "AZ", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Arizona [Member]", "label": "ARIZONA" } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsNotesAndLoansReceivableLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsNotesAndLoansReceivableLineItems", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesCreditLossReservesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued expenses", "totalLabel": "Accounts Payable and Accrued Liabilities, Total", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations." } } }, "auth_ref": [ "r99" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive income (loss), foreign currency translation adjustment, net of tax", "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax", "periodEndLabel": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax, Ending Balance", "periodStartLabel": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax, Beginning Balance", "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses." } } }, "auth_ref": [ "r202", "r203", "r204", "r205", "r469" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive (loss) income", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "totalLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r29", "r30", "r113", "r198", "r564", "r585", "r586" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive (Loss) Income [Member]", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r4", "r18", "r30", "r453", "r456", "r493", "r581", "r582", "r863", "r864", "r865", "r878", "r879", "r880" ] }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Weighted-average useful life of acquired intangible lease assets (in years)", "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r131" ] }, "mpw_AcquisitionLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "AcquisitionLoanMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Acquisition loan.", "label": "Acquisition Loan [Member]", "verboseLabel": "Acquisition Loans [Member]" } } }, "auth_ref": [] }, "mpw_AcquisitionLoansAndOtherLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "AcquisitionLoansAndOtherLoans", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Acquisition loans and other loans.", "label": "Acquisition Loans And Other Loans", "terseLabel": "Other loans" } } }, "auth_ref": [] }, "mpw_AcuteCareCampusMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "AcuteCareCampusMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Acute care campus.", "label": "Acute Care Campus [Member]", "terseLabel": "Acute Care Campus [Member]" } } }, "auth_ref": [] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]", "terseLabel": "Additional 402(v) Disclosure" } } }, "auth_ref": [ "r804" ] }, "mpw_AdditionalCashProceedsOfNonRecourseSecuredFinance": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "AdditionalCashProceedsOfNonRecourseSecuredFinance", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional cash proceeds of non-recourse secured finance", "label": "Additional Cash Proceeds Of Non-Recourse Secured Finance", "documentation": "Additional Cash Proceeds Of Non-Recourse Secured Finance" } } }, "auth_ref": [] }, "mpw_AdditionalImpairmentChargesOnEquityInvestmentAndLoansDueFromAffiliates": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "AdditionalImpairmentChargesOnEquityInvestmentAndLoansDueFromAffiliates", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional impairment charges on equity investment and loans due from affiliates", "label": "Additional Impairment Charges On Equity Investment And Loans Due From Affiliates", "documentation": "Additional Impairment Charges On Equity Investment And Loans Due From Affiliates" } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional Paid in Capital, Common Stock", "terseLabel": "Additional paid-in capital", "periodStartLabel": "Additional Paid in Capital, Common Stock, Beginning Balance", "periodEndLabel": "Additional Paid in Capital, Common Stock, Ending Balance", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r108" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r426", "r427", "r428", "r596", "r878", "r879", "r880", "r905", "r935" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount", "terseLabel": "Adjustment to Compensation, Amount" } } }, "auth_ref": [ "r810" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]", "terseLabel": "Adjustment to Compensation:" } } }, "auth_ref": [ "r810" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]", "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "auth_ref": [ "r810" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]", "terseLabel": "Adjustment To PEO Compensation, Footnote" } } }, "auth_ref": [ "r810" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net (loss) income to net cash provided by operating activities:", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "mpw_AdvancementOfRedevelopmentRecoveryReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "AdvancementOfRedevelopmentRecoveryReceivables", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Advancement of redevelopment recovery receivables", "label": "Advancement Of Redevelopment Recovery Receivables", "documentation": "Advancement of redevelopment recovery receivables." } } }, "auth_ref": [] }, "mpw_AevisVictoriaSAMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "AevisVictoriaSAMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Aevis Victoria SA.", "label": "Aevis Victoria S A [Member]", "terseLabel": "Aevis Victoria SA [Member]" } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount", "terseLabel": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r775", "r786", "r796", "r821" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]", "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "auth_ref": [ "r778", "r789", "r799", "r824" ] }, "mpw_AlectoHealthcareServicesLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "AlectoHealthcareServicesLlcMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Alecto Healthcare Services LLC [Member]", "label": "Alecto Healthcare Services LLC [Member]", "documentation": "Alecto healthcare services llc." } } }, "auth_ref": [] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Adjustments to Compensation [Member]", "terseLabel": "All Adjustments to Compensation" } } }, "auth_ref": [ "r810" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Executive Categories [Member]", "terseLabel": "All Executive Categories" } } }, "auth_ref": [ "r817" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Individuals [Member]", "terseLabel": "All Individuals" } } }, "auth_ref": [ "r782", "r790", "r800", "r817", "r825", "r829", "r837" ] }, "mpw_AllOtherCountriesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "AllOtherCountriesMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "All Other Countries [Member]", "label": "All Other Countries [Member]", "documentation": "All other countries." } } }, "auth_ref": [] }, "mpw_AllOtherStatesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "AllOtherStatesMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "All Other States [Member]", "label": "All Other States [Member]", "documentation": "All other states." } } }, "auth_ref": [] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "All Trading Arrangements [Member]", "terseLabel": "All Trading Arrangements" } } }, "auth_ref": [ "r835" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableRecoveries", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesCreditLossReservesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, Allowance for Credit Loss, Recovery", "terseLabel": "Credit loss recovery", "documentation": "Amount of increase in allowance for credit loss on accounts receivable, from recovery." } } }, "auth_ref": [ "r326" ] }, "us-gaap_AlternativeInvestmentMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AlternativeInvestmentMeasurementInput", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Investments measurement input", "label": "Alternative Investment, Measurement Input", "documentation": "Value of input used to measure alternative investment." } } }, "auth_ref": [ "r467" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfFinancingCostsAndDiscounts", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Amortization of Debt Issuance Costs and Discounts", "terseLabel": "Amortization of deferred financing costs and debt discount", "totalLabel": "Amortization of Debt Issuance Costs and Discounts, Total", "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs." } } }, "auth_ref": [ "r370", "r485", "r733", "r734", "r872" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of Intangible Assets", "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r10", "r54", "r57" ] }, "mpw_AmountPayableToAssetBackedLendersOfAffiliateUponNonPaymentOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "AmountPayableToAssetBackedLendersOfAffiliateUponNonPaymentOfDebt", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Contingency arising from non payment of debt by affiliate to asset backed lenders", "label": "Amount Payable to Asset Backed Lenders of Affiliate upon Non Payment of Debt", "documentation": "Amount payable to asset backed lenders of affiliate upon non payment of debt." } } }, "auth_ref": [] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r443" ] }, "mpw_AsprisChildrensServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "AsprisChildrensServicesMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Aspris children's services.", "label": "Aspris Children's Services [Member]", "terseLabel": "Aspris Children's Services [Member]" } } }, "auth_ref": [] }, "us-gaap_AssetBackedSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetBackedSecuritiesMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Asset-Backed Securities [Member]", "terseLabel": "Asset Backed Credit Facility [Member]", "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans." } } }, "auth_ref": [ "r738", "r883", "r884", "r885" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Total Assets", "label": "Assets", "totalLabel": "Total Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r146", "r197", "r227", "r265", "r274", "r278", "r318", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r445", "r449", "r471", "r560", "r631", "r749", "r766", "r898", "r899", "r915" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "auth_ref": [] }, "us-gaap_AssetsSoldUnderAgreementsToRepurchaseAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsSoldUnderAgreementsToRepurchaseAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Securities or Other Assets Sold under Agreements to Repurchase [Axis]", "documentation": "Information by securities or other assets sold under repurchase agreements. Repurchase agreements are agreements under which the transferor (repo party) transfers a security to a transferee (repo counterparty or reverse party) in exchange for cash and concurrently agrees to reacquire that security at a future date for an amount equal to the cash exchanged plus a stipulated interest factor." } } }, "auth_ref": [ "r229" ] }, "us-gaap_AssetsSoldUnderAgreementsToRepurchaseTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsSoldUnderAgreementsToRepurchaseTypeDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Assets Sold under Agreements to Repurchase, Type [Domain]", "documentation": "This is the type of such assets (for example, US Treasury Obligations, US Government agency obligations and loans, and so forth). This item may be presented as an element in the table that is disclosed when the carrying amount (or market value, if higher than the carrying amount) of securities or other assets sold under repurchase agreements exceed 10 percent of total assets, as of the most recent balance sheet date." } } }, "auth_ref": [ "r229" ] }, "us-gaap_AssetsTotalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsTotalMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "Assets, Total [Member]", "terseLabel": "Total Gross Assets [Member]", "verboseLabel": "Total Assets", "documentation": "Total assets, when it serves as a benchmark in a concentration of risk calculation, representing the sum of all reported assets as of the balance sheet date." } } }, "auth_ref": [] }, "mpw_AustraliaFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "AustraliaFacilityMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Australian Term Loan Facility [Member]", "terseLabel": "Australia Facility", "label": "Australia Facility [Member]", "documentation": "Australia Facility [Member]" } } }, "auth_ref": [] }, "mpw_AustraliaTransactionMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "AustraliaTransactionMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Australia Transaction [Member]", "label": "Australia Transaction [Member]", "documentation": "Australia Transaction Member." } } }, "auth_ref": [] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price", "terseLabel": "Exercise Price" } } }, "auth_ref": [ "r832" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value", "terseLabel": "Fair Value as of Grant Date" } } }, "auth_ref": [ "r833" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]", "terseLabel": "Award Timing Disclosures" } } }, "auth_ref": [ "r828" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]", "terseLabel": "Award Timing, How MNPI Considered" } } }, "auth_ref": [ "r828" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]", "terseLabel": "Award Timing Method" } } }, "auth_ref": [ "r828" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]", "terseLabel": "Award Timing MNPI Considered" } } }, "auth_ref": [ "r828" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]", "terseLabel": "Award Timing MNPI Disclosure" } } }, "auth_ref": [ "r828" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]", "terseLabel": "Award Timing Predetermined" } } }, "auth_ref": [ "r828" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "terseLabel": "Award Type", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount", "terseLabel": "Underlying Securities" } } }, "auth_ref": [ "r831" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r830" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]", "terseLabel": "Awards Close in Time to MNPI Disclosures" } } }, "auth_ref": [ "r829" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]", "terseLabel": "Awards Close in Time to MNPI Disclosures, Table" } } }, "auth_ref": [ "r829" ] }, "us-gaap_BalanceSheetLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location", "documentation": "Information by location on balance sheet (statement of financial position)." } } }, "auth_ref": [] }, "us-gaap_BalanceSheetLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location", "documentation": "Location in the balance sheet (statement of financial position)." } } }, "auth_ref": [ "r87", "r88" ] }, "mpw_BehavioralHealthFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "BehavioralHealthFacilitiesMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "Behavioral Health Facilities [Member]", "documentation": "Behavioral health facilities." } } }, "auth_ref": [] }, "mpw_BehavioralHealthHospitalsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "BehavioralHealthHospitalsMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2024ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Behavioral Health Hospitals [Member]", "label": "Behavioral Health Hospitals [Member]", "documentation": "Behavioral health hospitals." } } }, "auth_ref": [] }, "mpw_BlueOwlReNucleusHoldcoLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "BlueOwlReNucleusHoldcoLlcMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Blue Owl RE Nucleus Holdco LLC", "label": "Blue Owl RE Nucleus Holdco LLC [Member]", "documentation": "Blue Owl RE Nucleus Holdco LLC [Member]" } } }, "auth_ref": [] }, "us-gaap_BridgeLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BridgeLoan", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bridge Loan", "label": "Bridge Loan", "documentation": "Short-Term financing which is expected to be paid back relatively quickly, such as by a subsequent longer-term loan. Also called swing loan or bridge financing." } } }, "auth_ref": [ "r102", "r147" ] }, "us-gaap_BuildingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BuildingMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "label": "Building [Member]", "terseLabel": "Building [Member]", "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities." } } }, "auth_ref": [ "r132" ] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDlomBySensitivityAnalysisByUsingBasisPointVariationsDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfActivityInCreditLossReservesParentheticalDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r441", "r741", "r742" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDlomBySensitivityAnalysisByUsingBasisPointVariationsDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfActivityInCreditLossReservesParentheticalDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r65", "r66", "r441", "r741", "r742" ] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesCoronavirusCovid19RentDeferralsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherUpdatesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesDesignatedAsHeldForSaleAndSoldDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r441" ] }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationConsiderationTransferred1", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Funded for interim mortgage loan", "label": "Business Combination, Consideration Transferred", "verboseLabel": "Purchase price of acquisition", "totalLabel": "Business Combination, Consideration Transferred, Total", "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer." } } }, "auth_ref": [ "r1", "r2", "r13" ] }, "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Sale of minority equity investment", "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable", "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination." } } }, "auth_ref": [ "r1", "r2" ] }, "mpw_BusinessCombinationLoansPaidDownOnAcquisitionLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "BusinessCombinationLoansPaidDownOnAcquisitionLoans", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Business combination loans paid down on acquisition loans.", "label": "Business Combination Loans Paid Down On Acquisition Loans", "verboseLabel": "Advanced to the mortgage loan", "negatedLabel": "Loans repaid", "terseLabel": "Loans repaid" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "label": "Additional mortgage loan", "terseLabel": "Total assets acquired", "verboseLabel": "Acquisition loan", "totalLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Total", "documentation": "Amount of assets acquired at the acquisition date." } } }, "auth_ref": [ "r68" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "negatedLabel": "Liabilities assumed", "totalLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities, Total", "documentation": "Amount of liabilities assumed at the acquisition date." } } }, "auth_ref": [ "r68" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net", "terseLabel": "Total net assets acquired", "totalLabel": "Total net assets acquired", "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed." } } }, "auth_ref": [ "r67", "r68" ] }, "us-gaap_BusinessCombinationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationsAbstract", "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]" } } }, "auth_ref": [] }, "stpr_CA": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "CA", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "California [Member]", "label": "CALIFORNIA", "terseLabel": "Stockton, California [Member]" } } }, "auth_ref": [] }, "country_CH": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "CH", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Switzerland [Member]", "label": "SWITZERLAND" } } }, "auth_ref": [] }, "country_CO": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "CO", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "COLOMBIA", "terseLabel": "Colombia [Member]" } } }, "auth_ref": [] }, "mpw_COVID19PandemicMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "COVID19PandemicMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "COVID - 19 pandemic.", "label": "C O V I D19 Pandemic [Member]", "terseLabel": "COVID-19 Pandemic [Member]" } } }, "auth_ref": [] }, "stpr_CT": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "CT", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "CONNECTICUT", "terseLabel": "Connecticut [Member]" } } }, "auth_ref": [] }, "mpw_CapitalRestructuringCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "CapitalRestructuringCosts", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Capital restructuring costs", "label": "Capital Restructuring Costs", "documentation": "Capital restructuring costs." } } }, "auth_ref": [] }, "mpw_CaremaxIncorporatedMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "CaremaxIncorporatedMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Caremax [Member]", "label": "CareMax Incorporated [Member]", "documentation": "CareMax Incorporated." } } }, "auth_ref": [] }, "mpw_CarryingValueOfLoanToAffiliate": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "CarryingValueOfLoanToAffiliate", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Carrying value of loan to affiliate", "label": "Carrying Value Of Loan To Affiliate", "documentation": "Carrying value of loan to affiliate." } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at beginning of period", "terseLabel": "Cash and cash equivalents", "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r42", "r195", "r718" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]", "verboseLabel": "Cash, cash equivalents, and restricted cash are comprised of the following:" } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of period", "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of period", "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r42", "r126", "r225" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "(Decrease) increase in cash, cash equivalents, and restricted cash for period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r3", "r126" ] }, "mpw_CatholicHealthInitiativesColoradoMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "CatholicHealthInitiativesColoradoMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Catholic Health Initiatives Colorado [Member]", "label": "Catholic Health Initiatives Colorado [Member]", "documentation": "Catholic health initiatives colorado." } } }, "auth_ref": [] }, "mpw_ChangeInInvestmentFairValueAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "ChangeInInvestmentFairValueAdjustments", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Unfavourable fair value adjustments", "terseLabel": "Change in fair value adjustments", "label": "Change in Investment Fair Value Adjustments", "documentation": "Change in investment fair value adjustments." } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]", "terseLabel": "Changed Peer Group, Footnote" } } }, "auth_ref": [ "r808" ] }, "mpw_CircleHealthMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "CircleHealthMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "documentation": "Circle Health Group.", "label": "Circle Health [Member]", "terseLabel": "Circle [Member]" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount", "terseLabel": "Company Selected Measure Amount" } } }, "auth_ref": [ "r809" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name", "terseLabel": "Company Selected Measure Name" } } }, "auth_ref": [ "r809" ] }, "us-gaap_CollateralAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CollateralAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Collateral Held [Axis]", "documentation": "Information by category of collateral or no collateral, from lender's perspective." } } }, "auth_ref": [ "r728" ] }, "us-gaap_CollateralDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CollateralDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Collateral Held [Domain]", "documentation": "Category of collateral or no collateral, from lender's perspective." } } }, "auth_ref": [] }, "mpw_CommitmentAndContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "CommitmentAndContingenciesLineItems", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Commitment And Contingencies [Line Items]", "label": "Commitment And Contingencies [Line Items]", "terseLabel": "Commitment And Contingencies [Line Items]" } } }, "auth_ref": [] }, "mpw_CommitmentAndContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "CommitmentAndContingenciesTable", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Commitment And Contingencies [Table]", "label": "Commitment And Contingencies [Table]", "terseLabel": "Commitment And Contingencies [Table]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r133", "r340", "r341", "r704", "r896" ] }, "mpw_CommonSpiritMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "CommonSpiritMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "CommonSpirit Health [Member]", "terseLabel": "Common Spirit [Member]", "label": "Common Spirit [Member]", "documentation": "Common spirit." } } }, "auth_ref": [] }, "us-gaap_CommonStockDividendsPerShareDeclared": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockDividendsPerShareDeclared", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "label": "Common Stock, Dividends, Per Share, Declared", "terseLabel": "Dividends declared per common share (unit)", "verboseLabel": "Dividends (Distributions) declared per common share / unit", "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding." } } }, "auth_ref": [ "r137" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "terseLabel": "Common Par Value [Member]", "verboseLabel": "Common Units [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r752", "r753", "r754", "r756", "r757", "r758", "r759", "r878", "r879", "r905", "r931", "r935" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r107" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r107", "r619" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued", "totalLabel": "Common Stock, Shares, Issued, Total", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r107" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding", "periodStartLabel": "Common Stock, Shares, Outstanding, Beginning Balance", "periodEndLabel": "Common Stock, Shares, Outstanding, Ending Balance", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r19", "r107", "r619", "r637", "r935", "r936" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, $0.001 par value. Authorized 750,000 shares; issued and outstanding - 600,304 shares at March 31, 2024 and 598,991 shares at December 31, 2023", "label": "Common Stock, Value, Issued", "totalLabel": "Common Stock, Value, Issued, Total", "periodStartLabel": "Common Stock, Value, Issued, Beginning Balance", "periodEndLabel": "Common Stock, Value, Issued, Ending Balance", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r107", "r563", "r749" ] }, "mpw_CommonUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "CommonUnitsMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "documentation": "Common units.", "label": "Common Units [Member]", "terseLabel": "Common Units" } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Company Selected Measure" } } }, "auth_ref": [ "r814" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]", "terseLabel": "Compensation Actually Paid vs. Net Income" } } }, "auth_ref": [ "r813" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Other Measure" } } }, "auth_ref": [ "r815" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]", "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "auth_ref": [ "r812" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveLossIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive (loss) income attributable to MPT common stockholders (Operating Partnership Partners)", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r31", "r209", "r211", "r219", "r554", "r576" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveLossIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive loss (income) attributable to non-controlling interests", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "negatedLabel": "Comprehensive income attributable to non-controlling interests", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r8", "r71", "r86", "r209", "r211", "r218", "r553", "r575" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveLossIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total comprehensive (loss) income", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r86", "r140", "r209", "r211", "r217", "r552", "r574" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r47", "r50", "r93", "r94", "r283", "r703" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r47", "r50", "r93", "r94", "r283", "r587", "r703" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r47", "r50", "r93", "r94", "r283", "r703", "r850" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk, Percentage", "verboseLabel": "Percentage of concentration risk", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r47", "r50", "r93", "r94", "r283" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r47", "r50", "r93", "r94", "r283", "r703" ] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited", "http://medicalpropertiestrust.com/20240331/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveLossIncomeUnaudited" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]", "terseLabel": "Consolidated Entities", "documentation": "Information by consolidated entity or group of entities." } } }, "auth_ref": [ "r180", "r232", "r445", "r446", "r449", "r450", "r497", "r714", "r859", "r860", "r861", "r897", "r900", "r901" ] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited", "http://medicalpropertiestrust.com/20240331/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveLossIncomeUnaudited" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]", "terseLabel": "Consolidated Entities", "documentation": "Entity or group of entities consolidated into reporting entity." } } }, "auth_ref": [ "r180", "r232", "r445", "r446", "r449", "r450", "r497", "r714", "r859", "r860", "r861", "r897", "r900", "r901" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Unaudited Interim Condensed Consolidated Financial Statements", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r72", "r722" ] }, "us-gaap_ConsolidationVariableInterestEntityPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationVariableInterestEntityPolicy", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]", "terseLabel": "Variable Interest Entities", "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined)." } } }, "auth_ref": [ "r73", "r77", "r80" ] }, "mpw_ConstructionInProgressEquipmentAndOther": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "ConstructionInProgressEquipmentAndOther", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "documentation": "Construction in progress equipment and other.", "label": "Construction In Progress Equipment And Other", "negatedLabel": "Construction in progress and other" } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiability", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Contract with Customer, Liability", "terseLabel": "Deferred revenue", "totalLabel": "Contract with Customer, Liability, Total", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r378", "r379", "r380" ] }, "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtTables" ], "lang": { "en-us": { "role": { "label": "Contractual Obligation, Fiscal Year Maturity [Table Text Block]", "terseLabel": "Principal Payments Due on Debt", "documentation": "Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation." } } }, "auth_ref": [ "r876" ] }, "us-gaap_ConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertibleDebt", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible loan", "label": "Convertible Debt", "totalLabel": "Convertible Debt, Total", "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company." } } }, "auth_ref": [ "r21", "r149", "r928" ] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Costs Incurred as of March 31, 2024", "label": "Cost of Goods and Services Sold", "totalLabel": "Cost of Goods and Services Sold, Total", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r118", "r536" ] }, "us-gaap_CostsAndExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpenses", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "label": "Costs and Expenses", "totalLabel": "Total expenses", "documentation": "Total costs of sales and operating expenses for the period." } } }, "auth_ref": [ "r117" ] }, "us-gaap_CostsAndExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostsAndExpensesAbstract", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "label": "Costs and Expenses [Abstract]", "terseLabel": "Expenses" } } }, "auth_ref": [] }, "mpw_CostsOfLeasedAndRentedPropertyOrEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "CostsOfLeasedAndRentedPropertyOrEquipment", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "documentation": "Costs of leased and rented property or equipment.", "label": "Costs Of Leased And Rented Property Or Equipment", "terseLabel": "Property-related" } } }, "auth_ref": [] }, "srt_CounterpartyNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CounterpartyNameAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]", "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution." } } }, "auth_ref": [ "r190", "r230", "r231", "r358", "r375", "r496", "r719", "r721" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "mpw_CreditFacilityAmendmentAndAustraliaFacilityAmendmentMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "CreditFacilityAmendmentAndAustraliaFacilityAmendmentMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtCovenantsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility Amendment and Australia Facility Amendment [Member]", "label": "Credit Facility Amendment And Australia Facility Amendment [Member]", "documentation": "Credit Facility Amendment And Australia Facility Amendment [Member]" } } }, "auth_ref": [] }, "mpw_CreditFacilityAmendmentMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "CreditFacilityAmendmentMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility Amendment", "label": "Credit Facility Amendment [Member]", "documentation": "Credit Facility Amendment [Member]" } } }, "auth_ref": [] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtCovenantsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtCovenantsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility", "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "mpw_CumulativeBenefitCatchupFromAdjustingPayoutProbability": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "CumulativeBenefitCatchupFromAdjustingPayoutProbability", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Cumulative benefit catchup from adjusting payout probability", "label": "Cumulative Benefit Catchup From Adjusting Payout Probability", "documentation": "Cumulative benefit catchup from adjusting payout probability." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r48", "r283" ] }, "country_DE": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "DE", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Germany [Member]", "label": "GERMANY" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r21", "r103", "r104", "r147", "r149", "r232", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r486", "r730", "r731", "r732", "r733", "r734", "r874" ] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Gross", "terseLabel": "Debt", "totalLabel": "Total", "verboseLabel": "Principal amount", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r21", "r149", "r372" ] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Principal amount", "label": "Debt Instrument, Face Amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r96", "r98", "r355", "r486", "r731", "r732" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Fixed rate", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Senior unsecured notes, interest rate", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r24", "r356" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2024ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtCovenantsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r232", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r486", "r730", "r731", "r732", "r733", "r734", "r874" ] }, "us-gaap_DebtInstrumentMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentMaturityDate", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Maturity Date", "terseLabel": "Debt instrument maturity date", "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format." } } }, "auth_ref": [ "r174", "r730", "r907" ] }, "mpw_DebtInstrumentMaturityYear": { "xbrltype": "gYearItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "DebtInstrumentMaturityYear", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument maturity year", "documentation": "Debt instrument maturity year.", "label": "Debt Instrument Maturity Year" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r25", "r232", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r486", "r730", "r731", "r732", "r733", "r734", "r874" ] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2024ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtCovenantsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Schedule of Long-Term Debt Instruments [Table]", "terseLabel": "Debt Instrument [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r25", "r60", "r61", "r95", "r96", "r98", "r100", "r135", "r136", "r232", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r486", "r730", "r731", "r732", "r733", "r734", "r874" ] }, "us-gaap_DebtInstrumentTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTerm", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt insrtument term", "label": "Debt Instrument, Term", "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "mpw_DebtRefinancingAndUnutilizedFinancingBenefitCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "DebtRefinancingAndUnutilizedFinancingBenefitCosts", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "documentation": "Debt refinancing and unutilized financing (benefit) costs.", "label": "Debt Refinancing And Unutilized Financing (Benefit) Costs", "terseLabel": "Debt refinancing and unutilized financing (benefit) costs" } } }, "auth_ref": [] }, "mpw_DebtRefinancingCharge": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "DebtRefinancingCharge", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Debt refinancing charge.", "label": "Debt Refinancing Charge", "terseLabel": "Debt refinancing costs" } } }, "auth_ref": [] }, "mpw_DebtorInPossessionFinancingToAffiliateFundsProvided": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "DebtorInPossessionFinancingToAffiliateFundsProvided", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Bridge financing to affiliate", "label": "Debtor-In-Possession Financing to Affiliate, Funds Provided", "documentation": "Debtor-in-possession financing to affiliate, funds provided." } } }, "auth_ref": [] }, "us-gaap_DeferredFinanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsNet", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail" ], "lang": { "en-us": { "role": { "label": "Debt Issuance Costs, Net", "negatedLabel": "Debt issue costs and discount, net", "totalLabel": "Debt Issuance Costs, Net, Total", "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r97", "r903" ] }, "us-gaap_DeferredRentReceivablesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredRentReceivablesNet", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Cash rent", "label": "Deferred Rent Receivables, Net", "documentation": "Amount of excess of rental income recognized over rental payment required by lease." } } }, "auth_ref": [ "r164", "r165", "r166", "r911" ] }, "us-gaap_DepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationAndAmortization", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesDesignatedAsHeldForSaleAndSoldDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "label": "Depreciation, Depletion and Amortization, Nonproduction", "terseLabel": "Real estate depreciation and amortization", "totalLabel": "Depreciation, Depletion and Amortization, Nonproduction, Total", "negatedLabel": "Real estate depreciation and amortization", "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production." } } }, "auth_ref": [ "r10", "r58" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization", "totalLabel": "Depreciation, Depletion and Amortization, Total", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r10", "r269" ] }, "us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]", "documentation": "Indicates line item in statement of income or comprehensive income that includes gain (loss) from effective portion of derivative instrument reclassified from accumulated other comprehensive income (AOCI) into income." } } }, "auth_ref": [ "r451" ] }, "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Gains from our interest rate swap in AOCI", "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net", "totalLabel": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net, Total", "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments." } } }, "auth_ref": [ "r20", "r89" ] }, "us-gaap_DerivativeLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilities", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative liability", "label": "Derivative Liability", "totalLabel": "Derivative Liability, Total", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r200", "r201", "r470", "r599", "r600", "r601", "r603", "r605", "r606", "r607", "r609", "r610", "r632", "r634", "r635", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r721", "r932" ] }, "mpw_DevelopmentProjectAmountSpentOnCombinedBasis": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "DevelopmentProjectAmountSpentOnCombinedBasis", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Development project amount spent on combined basis", "label": "Development Project Amount Spent On Combined Basis", "documentation": "Development project amount spent on combined basis." } } }, "auth_ref": [] }, "mpw_DevelopmentProjectsEstimatedRentCommencementDate": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "DevelopmentProjectsEstimatedRentCommencementDate", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "documentation": "Development projects estimated rent commencement date.", "label": "Development Projects Estimated Rent Commencement Date", "terseLabel": "Estimated Rent Commencement Date" } } }, "auth_ref": [] }, "mpw_DevelopmentProjectsOriginalCommitmentAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "DevelopmentProjectsOriginalCommitmentAmount", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Total commitment", "documentation": "Development projects original commitment amount.", "label": "Development Projects Original Commitment Amount", "terseLabel": "Commitment" } } }, "auth_ref": [] }, "us-gaap_DirectFinancingLeaseLeaseIncomeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DirectFinancingLeaseLeaseIncomeTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "lang": { "en-us": { "role": { "label": "Direct Financing Lease, Lease Income [Table Text Block]", "terseLabel": "Components of Total Investment in Financing Leases", "documentation": "Tabular disclosure of components of lease income from direct financing lease." } } }, "auth_ref": [ "r263", "r489" ] }, "us-gaap_DirectFinancingLeaseLeaseReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DirectFinancingLeaseLeaseReceivable", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail" ], "lang": { "en-us": { "role": { "label": "Direct Financing Lease, Lease Receivable", "terseLabel": "Minimum lease payments receivable", "documentation": "Present value of lease payments not yet received by lessor and amount expected to be derived from underlying asset, following end of lease term, guaranteed by lessee or other third party unrelated to lessor, from direct financing lease." } } }, "auth_ref": [ "r491" ] }, "us-gaap_DirectFinancingLeaseNetInvestmentInLease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DirectFinancingLeaseNetInvestmentInLease", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail" ], "lang": { "en-us": { "role": { "label": "Direct Financing Lease, Net Investment in Lease, before Allowance for Credit Loss", "totalLabel": "Net investment in direct financing leases", "documentation": "Amount, before allowance for credit loss, of net investment in direct financing lease." } } }, "auth_ref": [ "r172", "r328", "r491", "r892" ] }, "us-gaap_DirectFinancingLeaseNetInvestmentInLeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DirectFinancingLeaseNetInvestmentInLeasesAbstract", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail" ], "lang": { "en-us": { "role": { "label": "Direct Financing Lease, Net Investment in Lease, before Allowance for Credit Loss [Abstract]", "terseLabel": "Direct Financing Lease Net Investment In Leases [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DirectFinancingLeaseRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DirectFinancingLeaseRevenue", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "label": "Direct Financing Lease, Revenue", "terseLabel": "Income from financing leases", "documentation": "Amount of direct financing lease revenue." } } }, "auth_ref": [ "r263", "r490" ] }, "mpw_DirectFinancingLeaseUnearnedIncomeAndAllowanceForCreditLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "DirectFinancingLeaseUnearnedIncomeAndAllowanceForCreditLoss", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail" ], "lang": { "en-us": { "role": { "documentation": "Direct financing lease, unearned income and allowance for credit loss.", "label": "Direct Financing Lease Unearned Income And Allowance For Credit Loss", "negatedLabel": "Less: Unearned income and allowance for credit loss" } } }, "auth_ref": [] }, "us-gaap_DirectFinancingLeaseUnguaranteedResidualAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DirectFinancingLeaseUnguaranteedResidualAsset", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail" ], "lang": { "en-us": { "role": { "label": "Direct Financing Lease, Unguaranteed Residual Asset", "terseLabel": "Estimated unguaranteed residual values", "documentation": "Present value expected to be derived from underlying asset, following end of lease term, not guaranteed by lessee or other third party unrelated to lessor." } } }, "auth_ref": [ "r491" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureStockAwards" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Text Block]", "terseLabel": "Stock Awards", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r391", "r395", "r422", "r423", "r425", "r744" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "mpw_DiscountForLackOfMarketabilityPercentage": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "DiscountForLackOfMarketabilityPercentage", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Discount for Lack of Marketability Percentage", "label": "Discount for Lack of Marketability Percentage", "terseLabel": "Discount for lack of marketability percentage on Springstone equity investment" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupClassificationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupClassificationAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesDesignatedAsHeldForSaleAndSoldDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group Classification [Axis]", "documentation": "Information by disposal group classification." } } }, "auth_ref": [ "r193" ] }, "us-gaap_DisposalGroupClassificationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupClassificationDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesDesignatedAsHeldForSaleAndSoldDetails" ], "lang": { "en-us": { "role": { "label": "Disposal Group Classification [Domain]", "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations." } } }, "auth_ref": [] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Agreegate agreed valuation", "label": "Disposal Group, Including Discontinued Operation, Consideration", "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation." } } }, "auth_ref": [] }, "us-gaap_DisposalGroupNotDiscontinuedOperationsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisposalGroupNotDiscontinuedOperationsMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesDesignatedAsHeldForSaleAndSoldDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group, Not Discontinued Operations [Member]", "label": "Disposal Group, Not Discontinued Operations [Member]", "documentation": "Disposal group that is not classified as discontinued operations." } } }, "auth_ref": [] }, "us-gaap_DividendPayableDateToBePaidDayMonthAndYear": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendPayableDateToBePaidDayMonthAndYear", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividend payable, date to be paid", "label": "Dividends Payable, Date to be Paid", "documentation": "Date the declared dividend will be paid, in YYYY-MM-DD format." } } }, "auth_ref": [ "r43" ] }, "us-gaap_DividendsCommonStockCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsCommonStockCash", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "label": "Dividends, Common Stock, Cash", "negatedLabel": "Dividends (Distributions) declared", "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash." } } }, "auth_ref": [ "r137" ] }, "mpw_DividendsDeclaredAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "DividendsDeclaredAdjustment", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends declared adjustment", "label": "Dividends Declared Adjustment", "documentation": "Dividends declared adjustment" } } }, "auth_ref": [] }, "us-gaap_DividendsPayableAmountPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsPayableAmountPerShare", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash dividend declared per share", "label": "Dividends Payable, Amount Per Share", "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date." } } }, "auth_ref": [ "r43" ] }, "us-gaap_DividendsPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsPayableCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends/Distributions declared, unpaid", "label": "Dividends Payable", "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding." } } }, "auth_ref": [ "r104", "r105", "r148", "r763", "r927" ] }, "us-gaap_DividendsPayableDateDeclaredDayMonthAndYear": { "xbrltype": "dateItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsPayableDateDeclaredDayMonthAndYear", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividend payable, date declared", "label": "Dividends Payable, Date Declared", "documentation": "Date the dividend to be paid was declared, in YYYY-MM-DD format." } } }, "auth_ref": [ "r43" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Information [Table]", "terseLabel": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r770" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "terseLabel": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r803" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "country_ES": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "ES", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Spain [Member]", "label": "SPAIN" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Net (loss) income attributable to MPT common stockholders (Operating Partnership partners), basic", "label": "Earnings Per Share, Basic", "totalLabel": "Earnings Per Share, Basic, Total", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r220", "r238", "r239", "r240", "r241", "r242", "r248", "r250", "r256", "r257", "r258", "r262", "r460", "r461", "r555", "r577", "r724" ] }, "us-gaap_EarningsPerShareBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasicAbstract", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings per common share (units) basic", "label": "Earnings Per Share, Basic [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasicLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasicLineItems", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]", "terseLabel": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r250", "r254", "r256" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Net (loss) income attributable to MPT common stockholders (Operating Partnership partners), diluted", "label": "Earnings Per Share, Diluted", "totalLabel": "Earnings Per Share, Diluted, Total", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r220", "r238", "r239", "r240", "r241", "r242", "r250", "r256", "r257", "r258", "r262", "r460", "r461", "r555", "r577", "r724" ] }, "us-gaap_EarningsPerShareDilutedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDilutedAbstract", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings per common share (units) diluted", "label": "Earnings Per Share, Diluted [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareUnit" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings Per Share/Unit", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r247", "r259", "r260", "r261" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "terseLabel": "Effect of exchange rate changes", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r474" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Employee Stock Option [Member]", "terseLabel": "Employee Stock Option", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r768" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r768" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Securities Act File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "terseLabel": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r768" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r842" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r768" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "terseLabel": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r768" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "terseLabel": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r768" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r768" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical" ], "lang": { "en-us": { "role": { "label": "Equity Component [Domain]", "terseLabel": "Equity Component", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r19", "r191", "r212", "r213", "r214", "r233", "r234", "r235", "r237", "r243", "r245", "r264", "r319", "r320", "r377", "r426", "r427", "r428", "r434", "r435", "r452", "r453", "r454", "r455", "r456", "r457", "r459", "r477", "r478", "r479", "r480", "r481", "r482", "r493", "r581", "r582", "r583", "r596", "r658" ] }, "mpw_EquityIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "EquityIncentivePlanMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Equity incentive plan member.", "label": "Equity Incentive Plan [Member]", "terseLabel": "Equity Incentive Plan [Member]" } } }, "auth_ref": [] }, "mpw_EquityInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "EquityInvestment", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Equity investment", "label": "Equity Investment", "documentation": "Equity investment." } } }, "auth_ref": [] }, "mpw_EquityInvestmentsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "EquityInvestmentsPercentage", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Equity investments percentage", "label": "Equity Investments Percentage", "documentation": "Equity investments percentage." } } }, "auth_ref": [] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]", "documentation": "Name of investment including named security. Excludes entity that is consolidated." } } }, "auth_ref": [ "r315", "r316", "r317" ] }, "mpw_EquityMethodInvestmentAndOtherLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "EquityMethodInvestmentAndOtherLoansMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Investments in Unconsolidated Operating Entities [Member]", "documentation": "Equity method investment and other loans.", "label": "Equity Method Investment And Other Loans [Member]", "terseLabel": "Equity Method Investment and Other Loans [Member]" } } }, "auth_ref": [] }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentOwnershipPercentage", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ownership interest", "verboseLabel": "Passive equity interest", "label": "Percentage of equity investment", "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting." } } }, "auth_ref": [ "r315" ] }, "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentsAndJointVenturesAbstract", "lang": { "en-us": { "role": { "label": "Equity Method Investments and Joint Ventures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesFvNiUnrealizedGainLoss", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Equity investments unrealized gain/loss", "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)", "totalLabel": "Equity Securities, FV-NI, Unrealized Gain (Loss), Total", "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)." } } }, "auth_ref": [ "r578", "r890" ] }, "us-gaap_EquitySecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Securities [Member]", "label": "Equity Securities [Member]", "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants." } } }, "auth_ref": [ "r53", "r760", "r761", "r762", "r938" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]", "terseLabel": "Equity Valuation Assumption Difference, Footnote" } } }, "auth_ref": [ "r811" ] }, "mpw_ErnestHealthIncMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "ErnestHealthIncMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Ernest Health, Inc.", "label": "Ernest Health Inc [Member]", "verboseLabel": "Ernest Health Inc [Member]", "terseLabel": "Ernest [Member]" } } }, "auth_ref": [] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]", "terseLabel": "Erroneous Compensation Analysis" } } }, "auth_ref": [ "r775", "r786", "r796", "r821" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]", "terseLabel": "Erroneously Awarded Compensation Recovery" } } }, "auth_ref": [ "r772", "r783", "r793", "r818" ] }, "mpw_EstimatedConcentrationRiskPercentage": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "EstimatedConcentrationRiskPercentage", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails" ], "lang": { "en-us": { "role": { "documentation": "Estimated concentration risk percentage.", "label": "Estimated Concentration Risk Percentage", "terseLabel": "Estimated concentration risk" } } }, "auth_ref": [] }, "mpw_EstimatedFeesToSellTheHospitals": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "EstimatedFeesToSellTheHospitals", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated fees to sell the hospitals", "label": "Estimated Fees To Sell The Hospitals", "documentation": "Estimated fees to Sell the hospitals." } } }, "auth_ref": [] }, "mpw_EuroDenominatedBorrowingsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "EuroDenominatedBorrowingsMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "EURO denominated borrowings.", "label": "EURO Denominated Borrowings [Member]", "terseLabel": "EURO-denominated Borrowings [Member]" } } }, "auth_ref": [] }, "srt_EuropeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EuropeMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Europe [Member]", "terseLabel": "Europe [Member]", "documentation": "Continent of Europe." } } }, "auth_ref": [ "r937", "r939", "r940", "r942" ] }, "mpw_ExceptedProceedsInCash": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "ExceptedProceedsInCash", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Excepted proceeds in cash", "label": "Excepted Proceeds in Cash", "documentation": "Excepted proceeds in cash." } } }, "auth_ref": [] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]", "terseLabel": "Executive Category:" } } }, "auth_ref": [ "r817" ] }, "stpr_FL": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "FL", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "FLORIDA", "terseLabel": "Florida [Member]" } } }, "auth_ref": [] }, "mpw_FacilitiesAcquired": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "FacilitiesAcquired", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Facilities acquired by the Prime", "label": "Facilities Acquired", "documentation": "Facilities acquired." } } }, "auth_ref": [] }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByBalanceSheetGroupingTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]", "terseLabel": "Summary of Fair Value Information of Financial Instruments", "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities." } } }, "auth_ref": [ "r91", "r92" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r363", "r382", "r383", "r384", "r385", "r386", "r387", "r464", "r504", "r505", "r506", "r731", "r732", "r738", "r739", "r740" ] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r463", "r464", "r466", "r467", "r468" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstruments" ], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value of Financial Instruments", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r462" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Level 3 [Member]", "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r363", "r382", "r383", "r384", "r385", "r386", "r387", "r464", "r506", "r731", "r732", "r738", "r739", "r740" ] }, "mpw_FairValueMeasurementDiscountRate": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "FairValueMeasurementDiscountRate", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Discount rate on investment", "label": "Fair Value Measurement Discount Rate", "documentation": "Fair value measurement discount rate." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency", "documentation": "Measurement frequency." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r363", "r382", "r383", "r384", "r385", "r386", "r387", "r504", "r505", "r506", "r731", "r732", "r738", "r739", "r740" ] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value, Recurring [Member]", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r462", "r468" ] }, "mpw_FavorableFairMarketValueAdjustmentOnInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "FavorableFairMarketValueAdjustmentOnInvestment", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Favorable fair market value adjustment on investment.", "label": "Favorable Fair Market Value Adjustment On Investment", "terseLabel": "Favorable fair market value adjustment on investment" } } }, "auth_ref": [] }, "mpw_FavorableNonCashFairValueAdjustmentOnInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "FavorableNonCashFairValueAdjustmentOnInvestment", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Favorable non-cash fair value adjustment on investment.", "label": "Favorable Non Cash Fair Value Adjustment On Investment", "terseLabel": "Favorable non-cash fair value adjustment on investment" } } }, "auth_ref": [] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialInstrumentAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r322", "r323", "r328", "r329", "r330", "r331", "r332", "r333", "r371", "r376", "r458", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r573", "r729", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r886", "r887", "r888", "r889" ] }, "mpw_FinancialInstrumentsMeasuredAtFairValueOnRecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "FinancialInstrumentsMeasuredAtFairValueOnRecurringBasisLineItems", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDlomBySensitivityAnalysisByUsingBasisPointVariationsDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Financial instruments measured at fair value on recurring basis.", "label": "Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]", "terseLabel": "Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]" } } }, "auth_ref": [] }, "mpw_FinancialInstrumentsMeasuredAtFairValueOnRecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "FinancialInstrumentsMeasuredAtFairValueOnRecurringBasisTable", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDlomBySensitivityAnalysisByUsingBasisPointVariationsDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Financial Instruments Measured At Fair Value On Recurring Basis [Table]", "label": "Financial Instruments Measured At Fair Value On Recurring Basis [Table]", "terseLabel": "Financial Instruments Measured At Fair Value On Recurring Basis [Table]" } } }, "auth_ref": [] }, "us-gaap_FinancingReceivableAllowanceForCreditLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancingReceivableAllowanceForCreditLosses", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfActivityInCreditLossReservesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance at beginning of the period", "periodEndLabel": "Balance at end of the period", "label": "Financing Receivable, Allowance for Credit Loss", "documentation": "Amount of allowance for credit loss on financing receivable. Excludes allowance for financing receivable covered under loss sharing agreement." } } }, "auth_ref": [ "r14", "r175", "r176", "r177", "r199", "r321", "r324", "r327", "r924" ] }, "us-gaap_FinancingReceivableAllowanceForCreditLossesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancingReceivableAllowanceForCreditLossesLineItems", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfActivityInCreditLossReservesParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, Allowance for Credit Loss [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r178", "r893" ] }, "mpw_FinancingReceivableAllowancesOfCreditLossesRelatedToFinancialInstrumentsSold": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "FinancingReceivableAllowancesOfCreditLossesRelatedToFinancialInstrumentsSold", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfActivityInCreditLossReservesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected credit loss reserve related to financial instruments sold, repaid, or satisfied", "label": "Financing Receivable Allowances Of Credit Losses Related To Financial Instruments Sold", "documentation": "Financing Receivable Allowances Of Credit Losses Related To Financial Instruments Sold" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r334", "r335", "r336", "r337", "r537", "r538" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r55", "r56" ] }, "mpw_FirstLienSecuredLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "FirstLienSecuredLoan", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "First lien secured loan", "label": "First Lien Secured Loan", "documentation": "First lien secured loan." } } }, "auth_ref": [] }, "mpw_FivePointTwoFiveZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "FivePointTwoFiveZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "5.250% Senior Unsecured Notes due 2026 [Member]", "documentation": "Five point two five zero percentage senior unsecured notes due two thousand twenty six.", "label": "Five Point Two Five Zero Percentage Senior Unsecured Notes Due Two Thousand Twenty Six [Member]" } } }, "auth_ref": [] }, "mpw_FivePointZeroZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySevenMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "FivePointZeroZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySevenMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "5.000% Senior Unsecured Notes due 2027 [Member]", "documentation": "Five point zero zero zero percentage senior unsecured notes due two thousand twenty seven.", "label": "Five Point Zero Zero Zero Percentage Senior Unsecured Notes Due Two Thousand Twenty Seven [Member]" } } }, "auth_ref": [] }, "us-gaap_ForeignCountryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCountryMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Foreign Tax Authority [Member]", "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile." } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r779", "r790", "r800", "r825" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount", "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r779", "r790", "r800", "r825" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount", "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r779", "r790", "r800", "r825" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]", "terseLabel": "Forgone Recovery, Explanation of Impracticability" } } }, "auth_ref": [ "r779", "r790", "r800", "r825" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r779", "r790", "r800", "r825" ] }, "mpw_FourPointSixTwoFivePercentageSeniorUnsecuredNotesDueTwoThousandTwentyNineMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "FourPointSixTwoFivePercentageSeniorUnsecuredNotesDueTwoThousandTwentyNineMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "4.625% Senior Unsecured Notes due 2029 [Member]", "documentation": "Four point six two five percentage senior unsecured notes due two thousand twenty nine.", "label": "Four Point Six Two Five Percentage Senior Unsecured Notes Due Two Thousand Twenty Nine [Member]" } } }, "auth_ref": [] }, "mpw_FreestandingERUrgentCareFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "FreestandingERUrgentCareFacilitiesMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Freestanding ER/Urgent Care Facilities [Member]", "label": "Freestanding E R Urgent Care Facilities [Member]", "documentation": "Freestanding E R urgent care facilities." } } }, "auth_ref": [] }, "mpw_FundingOfRedevelopmentRecoveryReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "FundingOfRedevelopmentRecoveryReceivables", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Funding of redevelopment recovery receivables.", "label": "Funding of Redevelopment Recovery Receivables", "terseLabel": "Funding of redevelopment recovery receivables." } } }, "auth_ref": [] }, "country_GB": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "GB", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "United Kingdom [Member]", "terseLabel": "British Pound Sterling [Member]", "label": "UNITED KINGDOM" } } }, "auth_ref": [] }, "mpw_GBPDenominatedBorrowingsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "GBPDenominatedBorrowingsMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "GBP-denominated Borrowings [Member]", "label": "G B P Denominated Borrowings [Member]", "terseLabel": "GBP-denominated Borrowings [Member]" } } }, "auth_ref": [] }, "mpw_GainLossOnDispositionOfRealEstate": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "GainLossOnDispositionOfRealEstate", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesDesignatedAsHeldForSaleAndSoldDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Income from real estate dispositions, net", "label": "Gain Loss on Disposition of Real Estate", "documentation": "Gain loss on disposition of real estate." } } }, "auth_ref": [] }, "us-gaap_GainLossOnDispositionOfRealEstateDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnDispositionOfRealEstateDiscontinuedOperations", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2024ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Gain (loss) on real estate dispositions", "label": "Gain (Loss) on Disposition of Real Estate, Discontinued Operations", "documentation": "Amount of difference between the carrying amount and the sales price of real estate properties sold as part of discontinued operations." } } }, "auth_ref": [] }, "us-gaap_GainLossOnInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnInvestments", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Economic loss", "label": "Gain (Loss) on Investments", "totalLabel": "Gain (Loss) on Investments, Total", "documentation": "Amount of realized and unrealized gain (loss) on investment." } } }, "auth_ref": [ "r121", "r843" ] }, "mpw_GainLossOnSaleOfInterestInSyndicatedTermLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "GainLossOnSaleOfInterestInSyndicatedTermLoan", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Loss on sale of Interest in syndicated term loan", "terseLabel": "Gain (loss) on sale of interest in syndicated term loan", "label": "Gain (Loss) on Sale of Interest in Syndicated Term Loan", "documentation": "Gain (Loss) on Sale of Interest in Syndicated Term Loan" } } }, "auth_ref": [] }, "us-gaap_GainsLossesOnSalesOfInvestmentRealEstate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainsLossesOnSalesOfInvestmentRealEstate", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Loss (gain) on sale of real estate", "label": "Gains (Losses) on Sales of Investment Real Estate", "terseLabel": "(Loss) gain on sale of real estate", "documentation": "The net gain (loss) resulting from sales and other disposals of real estate owned for investment purposes." } } }, "auth_ref": [ "r169", "r170", "r171", "r866", "r867", "r872", "r925", "r934" ] }, "mpw_GeneralAcuteCareFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "GeneralAcuteCareFacilityMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2024ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "General Acute Care Facility [Member]", "label": "General Acute Care Facility [Member]", "documentation": "General acute care facility." } } }, "auth_ref": [] }, "mpw_GeneralAcuteCareHospitalsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "GeneralAcuteCareHospitalsMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "documentation": "General acute care hospitals.", "label": "General Acute Care Hospitals [Member]", "terseLabel": "General Acute Care Hospitals [Member]", "verboseLabel": "General Acute Care Facilities [Member]" } } }, "auth_ref": [] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "label": "General and Administrative Expense", "terseLabel": "General and administrative", "totalLabel": "General and Administrative Expense, Total", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r119", "r641" ] }, "us-gaap_GeneralPartnerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralPartnerMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical" ], "lang": { "en-us": { "role": { "label": "General Partner [Member]", "terseLabel": "General Partner [Member]", "documentation": "Party to a partnership business who has unlimited liability." } } }, "auth_ref": [] }, "us-gaap_GeneralPartnersCapitalAccount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralPartnersCapitalAccount", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "General Partner - issued and outstanding - 6,004 units at March 31, 2024 and 5,991 units at December 31, 2023", "label": "General Partners' Capital Account", "totalLabel": "General Partners' Capital Account, Total", "documentation": "The amount of the general partner's ownership interest." } } }, "auth_ref": [ "r138" ] }, "us-gaap_GeneralPartnersCapitalAccountUnitsIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralPartnersCapitalAccountUnitsIssued", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "General Partners' Capital Account, Units Issued", "terseLabel": "General partner, units issued", "documentation": "The number of general partner units issued." } } }, "auth_ref": [ "r138" ] }, "us-gaap_GeneralPartnersCapitalAccountUnitsOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeneralPartnersCapitalAccountUnitsOutstanding", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "General Partners' Capital Account, Units Outstanding", "terseLabel": "General partner, units outstanding", "documentation": "The number of general partner units outstanding." } } }, "auth_ref": [ "r138" ] }, "us-gaap_GeographicConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GeographicConcentrationRiskMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "Geographic Concentration Risk [Member]", "terseLabel": "Geographic Concentration [Member]", "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa)." } } }, "auth_ref": [ "r49", "r703" ] }, "mpw_GlobalAssetManagerMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "GlobalAssetManagerMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Global Asset Manager.", "label": "Global Asset Manager [Member]" } } }, "auth_ref": [] }, "mpw_GrossInvestmentInRealEstateAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "GrossInvestmentInRealEstateAssets", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Gross investment in real estate assets", "label": "Gross Investment In Real Estate Assets", "totalLabel": "Gross investment in real estate assets" } } }, "auth_ref": [] }, "mpw_HmHospitalMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "HmHospitalMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails" ], "lang": { "en-us": { "role": { "documentation": "HM Hospital.", "label": "HM Hospital [Member]", "terseLabel": "HM Hospital [Member]" } } }, "auth_ref": [] }, "mpw_ImedHospitalesOneFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "ImedHospitalesOneFacilityMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "IMED [Member]", "label": "IMED Hospitales One Facility [Member]", "documentation": "IMED Hospitales One Facility." } } }, "auth_ref": [] }, "mpw_ImedHospitalesThreeFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "ImedHospitalesThreeFacilityMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "IMED [Member]", "label": "IMED Hospitales Three Facility [Member]", "documentation": "IMED hospitales Three facility." } } }, "auth_ref": [] }, "mpw_ImedHospitalesTwoFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "ImedHospitalesTwoFacilitiesMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "IMED [Member]", "label": "IMED Hospitales Two Facilities [Member]", "documentation": "IMED Hospitales Two Facilities." } } }, "auth_ref": [] }, "mpw_ImpairmentAndOtherCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "ImpairmentAndOtherCharges", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment and other charges", "label": "Impairment And Other Charges", "documentation": "Impairment And Other Charges" } } }, "auth_ref": [] }, "mpw_ImpairmentChargesAndFairValueAdjustmentsOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "ImpairmentChargesAndFairValueAdjustmentsOfEquity", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment charges and fair value adjustments of equity", "label": "Impairment Charges and Fair Value Adjustments of Equity", "documentation": "Impairment charges and fair value adjustments of equity" } } }, "auth_ref": [] }, "mpw_ImpairmentChargesEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "ImpairmentChargesEquity", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Equity impairment charges", "label": "Impairment Charges Equity", "documentation": "Impairment charges equity." } } }, "auth_ref": [] }, "us-gaap_ImpairmentOfRealEstate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfRealEstate", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherUpdatesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Impairment charge", "terseLabel": "Net impairment charge", "label": "Impairment of Real Estate", "documentation": "The charge against earnings in the period to reduce the carrying amount of real property to fair value." } } }, "auth_ref": [ "r872", "r894" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "(Loss) income before income tax", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r114", "r154", "r265", "r273", "r277", "r279", "r556", "r569", "r726" ] }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromEquityMethodInvestments", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "label": "Income (Loss) from Equity Method Investments", "terseLabel": "Earnings from equity interests", "totalLabel": "Income (Loss) from Equity Method Investments, Total", "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)." } } }, "auth_ref": [ "r10", "r115", "r153", "r270", "r314", "r568" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r338", "r339", "r642" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Income Statement Location [Domain]", "documentation": "Location in the income statement." } } }, "auth_ref": [ "r339", "r642" ] }, "us-gaap_IncomeTaxAuthorityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Income Tax Authority [Axis]", "documentation": "Information by tax jurisdiction." } } }, "auth_ref": [ "r16" ] }, "us-gaap_IncomeTaxAuthorityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxAuthorityDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Income Tax Authority [Domain]", "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "auth_ref": [] }, "mpw_IncomeTaxBenefitRelatedToTheInitialLoanImpairment": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "IncomeTaxBenefitRelatedToTheInitialLoanImpairment", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Income tax benefit related to the initial loan impairment", "label": "Income Tax Benefit Related To The Initial Loan Impairment", "documentation": "Income tax benefit related to the initial loan impairment." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureIncomeTaxes1" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r228", "r429", "r431", "r432", "r433", "r436", "r438", "r439", "r440", "r593" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Income tax expense", "label": "Income Tax Expense (Benefit)", "totalLabel": "Income Tax Expense (Benefit), Total", "terseLabel": "Income tax expense (benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r168", "r173", "r244", "r245", "r271", "r430", "r437", "r579" ] }, "mpw_IncomeTaxesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "IncomeTaxesLineItems", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Income Taxes [Line Items]", "label": "Income Taxes [Line Items]", "terseLabel": "Income Taxes [Line Items]" } } }, "auth_ref": [] }, "mpw_IncomeTaxesTable": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "IncomeTaxesTable", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Income Taxes [Table]", "label": "Income Taxes [Table]", "terseLabel": "Income Taxes [Table]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued expenses", "totalLabel": "Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInContractWithCustomerLiability", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Contract with Customer, Liability", "negatedLabel": "Deferred revenue", "terseLabel": "Deferred revenue", "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r535", "r871" ] }, "mpw_IncreaseDecreaseInInterestAndRentReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "IncreaseDecreaseInInterestAndRentReceivable", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "documentation": "Increase decrease in interest and rent receivable.", "label": "Increase Decrease In Interest And Rent Receivable", "negatedLabel": "Interest and rent receivables", "terseLabel": "Interest and rent receivables" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingAssets", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets", "totalLabel": "Increase (Decrease) in Other Operating Assets, Total", "documentation": "Amount of increase (decrease) in operating assets classified as other." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail" ], "lang": { "en-us": { "role": { "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "terseLabel": "Dilutive potential common shares", "totalLabel": "Incremental Common Shares Attributable to Share-based Payment Arrangements, Total", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method." } } }, "auth_ref": [ "r251", "r252", "r253", "r258", "r394" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]", "terseLabel": "Individual:" } } }, "auth_ref": [ "r782", "r790", "r800", "r817", "r825", "r829", "r837" ] }, "mpw_InflationBasedPercentageForAmendedLease": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "InflationBasedPercentageForAmendedLease", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2024ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Inflation-based percentage for amended lease", "label": "Inflation-based Percentage for Amended Lease", "documentation": "Inflation-based percentage for amended lease." } } }, "auth_ref": [] }, "mpw_InpatientRehabilitationHospitalMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "InpatientRehabilitationHospitalMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "documentation": "Inpatient Rehabilitation Hospital.", "label": "Inpatient Rehabilitation Hospital [Member]", "terseLabel": "Inpatient Rehabilitation Hospitals [Member]" } } }, "auth_ref": [] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]", "terseLabel": "Insider Trading Arrangements:" } } }, "auth_ref": [ "r835" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]", "terseLabel": "Insider Trading Policies and Procedures:" } } }, "auth_ref": [ "r771", "r841" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]", "terseLabel": "Insider Trading Policies and Procedures Adopted" } } }, "auth_ref": [ "r771", "r841" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]", "terseLabel": "Insider Trading Policies and Procedures Not Adopted" } } }, "auth_ref": [ "r771", "r841" ] }, "mpw_IntangibleLeaseAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "IntangibleLeaseAssetsMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Intangible Lease Assets", "terseLabel": "Intangible Lease Assets [Member]", "documentation": "Intangible Lease Assets", "label": "Intangible Lease Assets [Member]" } } }, "auth_ref": [] }, "us-gaap_InterestAndOtherIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestAndOtherIncome", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "label": "Interest and Other Income", "terseLabel": "Interest and other income", "totalLabel": "Interest and Other Income, Total", "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [] }, "mpw_InterestAndRentReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "InterestAndRentReceivable", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Interest and rent receivables", "documentation": "Interest and rent receivable.", "label": "Interest And Rent Receivable", "verboseLabel": "Interest and rent receivables, Book value" } } }, "auth_ref": [] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "label": "Interest Expense", "terseLabel": "Interest", "totalLabel": "Interest Expense, Total", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r97", "r158", "r215", "r268", "r484", "r643", "r764", "r933" ] }, "us-gaap_InterestPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaid", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities", "terseLabel": "Interest paid", "totalLabel": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities, Total", "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities." } } }, "auth_ref": [ "r873" ] }, "mpw_InterimCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "InterimCreditFacilityMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail" ], "lang": { "en-us": { "role": { "documentation": "Interim credit facility.", "label": "Interim Credit Facility [Member]", "terseLabel": "Interim Credit Facility [Member]" } } }, "auth_ref": [] }, "mpw_InternationalJointVentureMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "InternationalJointVentureMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "International joint venture.", "label": "International Joint Venture [Member]", "terseLabel": "International Joint Venture [Member]" } } }, "auth_ref": [] }, "mpw_InvestmentInPartnership": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "InvestmentInPartnership", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment in partnership", "label": "Investment In Partnership", "documentation": "Investment In Partnership" } } }, "auth_ref": [] }, "us-gaap_InvestmentIncomeDividend": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeDividend", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividend income", "label": "Investment Income, Dividend", "documentation": "Amount of dividend income on nonoperating securities." } } }, "auth_ref": [ "r120" ] }, "us-gaap_InvestmentOwnedAtCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentOwnedAtCost", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail" ], "lang": { "en-us": { "role": { "label": "Investment Owned, Cost", "terseLabel": "Book value", "verboseLabel": "Original Cost", "documentation": "Cost of the investment." } } }, "auth_ref": [ "r590", "r605", "r606", "r667", "r669", "r677", "r694", "r754", "r766", "r932" ] }, "us-gaap_InvestmentOwnedAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentOwnedAtFairValue", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail" ], "lang": { "en-us": { "role": { "periodEndLabel": "Investment Owned, at Fair Value, Ending Balance", "periodStartLabel": "Investment Owned, at Fair Value, Beginning Balance", "label": "Investment Owned, Fair Value", "terseLabel": "Fair Value", "documentation": "Fair value of investment in security owned." } } }, "auth_ref": [ "r590", "r599", "r600", "r601", "r603", "r604", "r605", "r606", "r608", "r611", "r612", "r622", "r623", "r662", "r665", "r666", "r668", "r675", "r676", "r678", "r679", "r680", "r690", "r691", "r693", "r695", "r696", "r754", "r766", "r932" ] }, "us-gaap_InvestmentTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTypeAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "label": "Investment Type [Axis]", "terseLabel": "Investment Type", "documentation": "Information by type of investments." } } }, "auth_ref": [ "r600", "r602", "r603", "r605", "r608", "r662", "r665", "r671", "r676", "r678", "r688", "r689", "r695", "r697", "r698", "r699", "r700", "r754" ] }, "us-gaap_InvestmentTypeCategorizationMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTypeCategorizationMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "label": "Investments [Domain]", "terseLabel": "Investments", "documentation": "Asset obtained to generate income or appreciate in value." } } }, "auth_ref": [ "r600", "r602", "r603", "r605", "r608", "r662", "r665", "r671", "r676", "r678", "r688", "r689", "r695", "r697", "r698", "r699", "r700", "r754" ] }, "us-gaap_InvestmentTypeExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentTypeExtensibleEnumeration", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Investment, Type [Extensible Enumeration]", "documentation": "Indicates type of investment. Includes, but is not limited to, common stock, preferred stock, convertible security, fixed income security, government security, option purchased, warrant, loan participation and assignment, commercial paper, bankers' acceptance, certificates of deposit, short-term security, repurchase agreement, and other investment company." } } }, "auth_ref": [ "r600", "r605", "r663", "r665", "r670", "r671", "r672", "r678", "r692", "r695" ] }, "us-gaap_Investments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Investments", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investments", "label": "Investments", "totalLabel": "Investments, Total", "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments." } } }, "auth_ref": [ "r558" ] }, "us-gaap_InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValuePeriodIncreaseDecrease", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDlomBySensitivityAnalysisByUsingBasisPointVariationsDetails" ], "lang": { "en-us": { "role": { "label": "Investments in and Advances to Affiliates, at Fair Value, Period Increase (Decrease)", "totalLabel": "Estimated Increase (Decrease) in Fair Value", "terseLabel": "Estimated Increase (Decrease) in Fair Value", "documentation": "Amount of increase (decrease) in the investments in and advances to affiliates." } } }, "auth_ref": [ "r941" ] }, "mpw_InvestmentsInOtherLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "InvestmentsInOtherLoans", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Investments in other loans.", "label": "Investments in Other Loans", "terseLabel": "Other loans" } } }, "auth_ref": [] }, "mpw_InvestmentsInUnconsolidatedOperatingEntities": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "InvestmentsInUnconsolidatedOperatingEntities", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Investments In Unconsolidated Operating Entities", "label": "Investments In Unconsolidated Operating Entities", "terseLabel": "Investments in unconsolidated operating entities" } } }, "auth_ref": [] }, "mpw_InvestmentsInUnconsolidatedOperatingEntitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "InvestmentsInUnconsolidatedOperatingEntitiesMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "documentation": "Investments In Unconsolidated Operating Entities [Member]", "label": "Investments In Unconsolidated Operating Entities [Member]", "terseLabel": "Investments In Unconsolidated Operating Entities [Member]" } } }, "auth_ref": [] }, "us-gaap_LandAndLandImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LandAndLandImprovementsMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "label": "Land and Land Improvements [Member]", "terseLabel": "Land and Land Improvements [Member]", "documentation": "Real estate held and assets that are an addition or improvement to real estate held." } } }, "auth_ref": [] }, "mpw_LandBuildingsAndImprovementsIntangibleLeaseAssetsAndOther": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "LandBuildingsAndImprovementsIntangibleLeaseAssetsAndOther", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Land buildings and improvements intangible lease assets and other.", "label": "Land Buildings And Improvements Intangible Lease Assets And Other", "terseLabel": "Land, buildings and improvements, intangible lease assets, and other" } } }, "auth_ref": [] }, "us-gaap_LeaseIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseIncome", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Master lease", "label": "Lease Income", "totalLabel": "Lease Income, Total", "documentation": "Amount of lease income from operating, direct financing, and sales-type leases. Includes, but is not limited to, variable lease payments, interest income, profit (loss) recognized at commencement, and lease payments paid and payable to lessor." } } }, "auth_ref": [ "r489" ] }, "mpw_LeasePurchaseOptionPriceReverts": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "LeasePurchaseOptionPriceReverts", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2024ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Lease purchase option price reverts", "label": "Lease Purchase Option Price Reverts", "documentation": "Lease purchase option price reverts." } } }, "auth_ref": [] }, "mpw_LeasePurchaseOptionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "LeasePurchaseOptionValue", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2024ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Lease purchase option value", "label": "Lease Purchase Option Value", "documentation": "Lease purchase option value." } } }, "auth_ref": [] }, "mpw_LeasedRealEstateAcquireLeaseBase": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "LeasedRealEstateAcquireLeaseBase", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Leased real estate acquire lease base", "label": "Leased Real Estate Acquire Lease Base", "documentation": "Leased Real Estate Acquire Lease Base" } } }, "auth_ref": [] }, "us-gaap_LeasesAcquiredInPlaceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeasesAcquiredInPlaceMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "In-place lease intangibles [Member]", "label": "Leases, Acquired-in-Place [Member]", "documentation": "This element represents the amount of value allocated by a lessor (acquirer) to lease agreements which exist at acquisition of a leased property. Such amount may include the value assigned to tenant relationships and excludes the market adjustment component of the value assigned for above or below-market leases acquired." } } }, "auth_ref": [] }, "mpw_LeasesAnnualRentEscalationsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "LeasesAnnualRentEscalationsPercentage", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Leases annual rent escalations percentage.", "label": "Leases Annual Rent Escalations Percentage", "terseLabel": "Annual rent escalations" } } }, "auth_ref": [] }, "mpw_LesseeOperatingLeaseExtendedExpirationYearOfContract": { "xbrltype": "gYearItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "LesseeOperatingLeaseExtendedExpirationYearOfContract", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Lease extension expiration year", "label": "Lessee Operating Lease Extended Expiration Year Of Contract", "documentation": "Lessee operating lease extended expiration year of contract." } } }, "auth_ref": [] }, "mpw_LesseeOperatingLeaseInitialFixedTermOfContract": { "xbrltype": "durationItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "LesseeOperatingLeaseInitialFixedTermOfContract", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Lessee operating lease initial fixed term of contract.", "label": "Lessee Operating Lease Initial Fixed Term Of Contract", "terseLabel": "Lease extension expiration term" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseTermOfContract", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Initial lease term", "label": "Lessee, Operating Lease, Term of Contract", "terseLabel": "Lease extension expiration term", "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r910" ] }, "us-gaap_LessorLeaseDescriptionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LessorLeaseDescriptionLineItems", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Lessor, Lease, Description [Line Items]", "terseLabel": "Lessor Lease Description [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r488" ] }, "us-gaap_LessorLeaseDescriptionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LessorLeaseDescriptionTable", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Lessor, Lease, Description [Table]", "terseLabel": "Lessor Lease Description [Table]", "documentation": "Disclosure of information about lessor's leases." } } }, "auth_ref": [ "r488" ] }, "us-gaap_LessorOperatingLeaseRenewalTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LessorOperatingLeaseRenewalTerm", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Lessor, Operating Lease, Renewal Term", "terseLabel": "Lease renewal term", "verboseLabel": "Term of lease extension, years", "documentation": "Term of lessor's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r912" ] }, "us-gaap_LessorOperatingLeaseTermOfContract": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LessorOperatingLeaseTermOfContract", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Term of lease", "label": "Lessor, Operating Lease, Term of Contract", "terseLabel": "Initial fixed terms of lease", "documentation": "Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r912" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities", "totalLabel": "Total Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r23", "r227", "r318", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r446", "r449", "r450", "r471", "r618", "r725", "r766", "r898", "r915", "r916" ] }, "us-gaap_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAbstract", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liabilities" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Equity / Capital", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r112", "r151", "r567", "r749", "r875", "r891", "r909" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and Equity" } } }, "auth_ref": [] }, "mpw_LifepointBehavioralMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "LifepointBehavioralMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lifepoint Behavioral [Member]", "label": "Lifepoint Behavioral [Member]", "documentation": "Lifepoint behavioral." } } }, "auth_ref": [] }, "us-gaap_LimitedPartnerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LimitedPartnerMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical" ], "lang": { "en-us": { "role": { "label": "Limited Partner [Member]", "terseLabel": "Limited Partner [Member]", "documentation": "Party to a partnership business who has limited liability." } } }, "auth_ref": [] }, "us-gaap_LimitedPartnersCapitalAccount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LimitedPartnersCapitalAccount", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Limited Partners - issued and outstanding - 594,300 units at March 31, 2024 and 593,000 units at December 31, 2023", "label": "Limited Partners' Capital Account", "totalLabel": "Limited Partners' Capital Account, Total", "documentation": "The amount of the limited partners' ownership interests." } } }, "auth_ref": [ "r138" ] }, "us-gaap_LimitedPartnersCapitalAccountUnitsIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LimitedPartnersCapitalAccountUnitsIssued", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Limited Partners' Capital Account, Units Issued", "terseLabel": "Limited Partners, units issued", "documentation": "The number of limited partner units issued." } } }, "auth_ref": [ "r138" ] }, "us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LimitedPartnersCapitalAccountUnitsOutstanding", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Limited Partners' Capital Account, Units Outstanding", "terseLabel": "Limited Partners, units outstanding", "documentation": "The number of limited partner units outstanding." } } }, "auth_ref": [ "r138" ] }, "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityCurrentBorrowingCapacity", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtCovenantsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Credit facility, current borrowing capacity", "label": "Line of Credit Facility, Current Borrowing Capacity", "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility." } } }, "auth_ref": [ "r22" ] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of credit facility, Borrowing capacity", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r22" ] }, "mpw_LoanDueFromAffiliates": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "LoanDueFromAffiliates", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfActivityInCreditLossReservesParentheticalDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loan due from affiliates", "label": "Loan Due From Affiliates", "documentation": "Loan Due From Affiliates" } } }, "auth_ref": [] }, "mpw_Loans": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "Loans", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail" ], "lang": { "en-us": { "role": { "documentation": "Loans.", "label": "Loans", "terseLabel": "Loans, Book value" } } }, "auth_ref": [] }, "mpw_LoansAndEquityInvestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "LoansAndEquityInvestmentsMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investments in Unconsolidated Operating Entities [Member]", "label": "Loans And Equity Investments [Member]", "documentation": "Loans and equity investments." } } }, "auth_ref": [] }, "mpw_LoansAndOrEquityInvestmentsInVariableInterestEntities": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "LoansAndOrEquityInvestmentsInVariableInterestEntities", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Loans and/or equity investments in variable interest entities.", "label": "Loans And Or Equity Investments In Variable Interest Entities", "terseLabel": "Loans and/or equity investments in variable interest entities" } } }, "auth_ref": [] }, "us-gaap_LoansHeldForSaleFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LoansHeldForSaleFairValueDisclosure", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail" ], "lang": { "en-us": { "role": { "label": "Loan, Held-for-Sale, Fair Value Disclosure", "terseLabel": "Loans, Fair value", "documentation": "Fair value portion of loans held-for-sale including, but not limited to, mortgage loans and finance receivables." } } }, "auth_ref": [] }, "us-gaap_LoansMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LoansMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Loans [Member]", "documentation": "When a lender gives money or property over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for [must receive] repayment [prior] relative to junior and unsecured (general) creditors." } } }, "auth_ref": [ "r52", "r723" ] }, "mpw_LoansNetAndEquityInvestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "LoansNetAndEquityInvestmentsMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loans, net and Equity Investments [Member]", "label": "Loans, Net And Equity Investments [Member]", "documentation": "Loans, net and equity investments." } } }, "auth_ref": [] }, "mpw_LoansTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "LoansTwoMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loans, Net Two [Member]", "label": "Loans Two [Member]", "documentation": "Loans two." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "mpw_LongTermAcuteCareHospitalMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "LongTermAcuteCareHospitalMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "documentation": "Long-term acute care hospital.", "label": "Long-term Acute Care Hospital [Member]", "terseLabel": "Long Term Acute Care Hospital [Member]" } } }, "auth_ref": [] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebt", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt", "terseLabel": "Debt, net", "totalLabel": "Debt, net", "negatedLabel": "Debt, net Book value", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r21", "r149", "r362", "r373", "r731", "r732", "r928" ] }, "us-gaap_LongTermDebtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtFairValue", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Fair Value", "negatedLabel": "Debt, net Fair value", "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission." } } }, "auth_ref": [] }, "mpw_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail" ], "lang": { "en-us": { "role": { "documentation": "Long term debt maturities repayments of principal after year four.", "label": "Long Term Debt Maturities Repayments Of Principal After Year Four", "terseLabel": "Thereafter" } } }, "auth_ref": [] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Long-Term Debt, Maturity, Year One", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r12", "r232", "r366" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Long-Term Debt, Maturity, Year Four", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r12", "r232", "r366" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Long-Term Debt, Maturity, Year Three", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r12", "r232", "r366" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Long-Term Debt, Maturity, Year Two", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r12", "r232", "r366" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtPrincipalPaymentsDueForDebtDetail" ], "lang": { "en-us": { "role": { "terseLabel": "2024", "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year." } } }, "auth_ref": [ "r877" ] }, "us-gaap_LongTermDebtTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebt" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt [Text Block]", "terseLabel": "Debt", "documentation": "The entire disclosure for long-term debt." } } }, "auth_ref": [ "r134" ] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r25" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Long-Term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r25", "r59" ] }, "stpr_MA": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "MA", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Massachusetts [Member]", "label": "MASSACHUSETTS" } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesCreditLossReservesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2024ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherUpdatesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]", "terseLabel": "Customer", "documentation": "Information by name or description of a single external customer or a group of external customers." } } }, "auth_ref": [ "r283", "r737", "r904", "r929", "r930" ] }, "us-gaap_MajorPropertyClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MajorPropertyClassAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "Major Property Class [Axis]", "terseLabel": "Major Property Class", "documentation": "Amount of property owned but leased or available for lease to third parties, by major property class." } } }, "auth_ref": [ "r167" ] }, "us-gaap_MajorPropertyClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MajorPropertyClassDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "Major Property Class [Domain]", "terseLabel": "Major Property Class", "documentation": "The major classes of assets leased or available for lease to third parties under operating lease agreements as of the balance sheet date." } } }, "auth_ref": [ "r167" ] }, "mpw_MassachusettsPartnershipMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "MassachusettsPartnershipMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Massachusetts Partnership [Member]", "label": "Massachusetts Partnership [Member]", "documentation": "Massachusetts partnership." } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2024ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum [Member]", "documentation": "Upper limit of the provided range." } } }, "auth_ref": [ "r342", "r343", "r344", "r345", "r389", "r534", "r580", "r609", "r610", "r664", "r670", "r673", "r674", "r692", "r715", "r716", "r727", "r735", "r743", "r751", "r902", "r917", "r918", "r919", "r920", "r921", "r922" ] }, "mpw_MaximumPercentageOfEntitysAssetsInvestedOnSingleProperty": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "MaximumPercentageOfEntitysAssetsInvestedOnSingleProperty", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "documentation": "Maximum percentage of entity's assets invested on single property.", "label": "Maximum Percentage Of Entitys Assets Invested On Single Property", "terseLabel": "Maximum percentage of entity's assets invested on single property" } } }, "auth_ref": [] }, "mpw_MaximumPercentageOfUnencumberedAssets": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "MaximumPercentageOfUnencumberedAssets", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtCovenantsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Maximum percentage of unencumbered assets.", "label": "Maximum Percentage Of Unencumbered Assets", "terseLabel": "Maximum percentage of total unencumbered assets" } } }, "auth_ref": [] }, "mpw_MaximumPermittedSecuredLeverageRatio": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "MaximumPermittedSecuredLeverageRatio", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum permitted secured leverage ratio", "label": "Maximum Permitted Secured Leverage Ratio", "documentation": "Maximum Permitted Secured Leverage Ratio" } } }, "auth_ref": [] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]", "terseLabel": "Measure:" } } }, "auth_ref": [ "r809" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure Name", "terseLabel": "Name" } } }, "auth_ref": [ "r809" ] }, "us-gaap_MeasurementInputDiscountRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputDiscountRateMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Discount Rate [Member]", "label": "Measurement Input, Discount Rate [Member]", "documentation": "Measurement input using interest rate to determine present value of future cash flows." } } }, "auth_ref": [ "r906" ] }, "us-gaap_MeasurementInputTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputTypeAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Measurement Input Type [Axis]", "documentation": "Information by type of measurement input used to determine value of asset and liability." } } }, "auth_ref": [ "r465" ] }, "us-gaap_MeasurementInputTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputTypeDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Measurement Input Type [Domain]", "documentation": "Measurement input used to determine value of asset and liability." } } }, "auth_ref": [] }, "mpw_MedianKlinikenSARLMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "MedianKlinikenSARLMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails" ], "lang": { "en-us": { "role": { "terseLabel": "MEDIAN [Member]", "documentation": "Median Kliniken S A R L [Member]", "label": "Median Kliniken S A R L [Member]" } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2024ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum [Member]", "documentation": "Lower limit of the provided range." } } }, "auth_ref": [ "r342", "r343", "r344", "r345", "r389", "r534", "r580", "r609", "r610", "r664", "r670", "r673", "r674", "r692", "r715", "r716", "r727", "r735", "r743", "r751", "r902", "r917", "r918", "r919", "r920", "r921", "r922" ] }, "mpw_MinimumPercentageOfReconcilingItemsQuantitativeThresholdOfTheStatutoryTax": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "MinimumPercentageOfReconcilingItemsQuantitativeThresholdOfTheStatutoryTax", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum percentage of reconciling items quantitative threshold of the statutory tax", "label": "Minimum Percentage Of Reconciling Items Quantitative Threshold Of The Statutory Tax", "documentation": "Minimum percentage of reconciling items quantitative threshold of the statutory tax." } } }, "auth_ref": [] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterest", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Equity, Attributable to Noncontrolling Interest", "terseLabel": "Non-controlling interests", "totalLabel": "Stockholders' Equity Attributable to Noncontrolling Interest, Total", "periodStartLabel": "Stockholders' Equity Attributable to Noncontrolling Interest, Beginning Balance", "periodEndLabel": "Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r28", "r150", "r227", "r318", "r346", "r348", "r349", "r350", "r353", "r354", "r471", "r566", "r621" ] }, "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders", "negatedLabel": "Distributions to non-controlling interests", "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders." } } }, "auth_ref": [ "r137" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]", "terseLabel": "MNPI Disclosure Timed for Compensation Value" } } }, "auth_ref": [ "r828" ] }, "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MortgageLoansOnRealEstateCommercialAndConsumerNet", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Mortgage Loans on Real Estate, Commercial and Consumer, Net", "terseLabel": "Mortgage loans", "totalLabel": "Mortgage Loans on Real Estate, Commercial and Consumer, Net, Total", "documentation": "The balance represents the amount of loans that are secured by real estate mortgages, offset by the reserve to cover probable credit losses on the loan portfolio." } } }, "auth_ref": [ "r557" ] }, "mpw_MortgagesAndOtherLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "MortgagesAndOtherLoansMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Mortgage and Other Loans [Member]", "label": "Mortgages and Other Loans [Member]", "documentation": "Mortgages and other loans." } } }, "auth_ref": [] }, "us-gaap_MortgagesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MortgagesMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsEquityInterestInRelatedPartyAndRelatedLoansMeasuredAtFairValueOnRecurringBasisDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Mortgages [Member]", "terseLabel": "Mortgage Loans [Member]", "documentation": "A loan to finance the purchase of real estate where the lender has a lien on the property as collateral for the loan." } } }, "auth_ref": [] }, "mpw_MptOperatingPartnershipLPMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "MptOperatingPartnershipLPMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited", "http://medicalpropertiestrust.com/20240331/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveLossIncomeUnaudited" ], "lang": { "en-us": { "role": { "documentation": "MPT Operating Partnership L.P", "label": "Mpt Operating Partnership L P [Member]", "terseLabel": "MPT Operating Partnership, L.P. [Member]" } } }, "auth_ref": [] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement [Text Block]", "terseLabel": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r836" ] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesCreditLossReservesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2024ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherUpdatesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]", "terseLabel": "Customer", "documentation": "Single external customer or group of external customers." } } }, "auth_ref": [ "r283", "r737", "r904", "r929", "r930" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]", "terseLabel": "Named Executive Officers, Footnote" } } }, "auth_ref": [ "r810" ] }, "mpw_NegativeHundredBasisPointsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "NegativeHundredBasisPointsMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDlomBySensitivityAnalysisByUsingBasisPointVariationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Negative Hundred Basis Points.", "label": "Negative Hundred Basis Points [Member]", "terseLabel": "- 100 Basis Points [Member]" } } }, "auth_ref": [] }, "mpw_NetBookValueOfLeasedProperty": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "NetBookValueOfLeasedProperty", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net book value of leased property", "label": "Net Book Value Of Leased Property", "documentation": "Net book value of leased property." } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used for) financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r224" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Financing activities" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash (used for) provided by investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r224" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Investing activities" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r126", "r127", "r128" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Operating activities" } } }, "auth_ref": [] }, "mpw_NetIncomeLessParticipatingSecuritiesShareInEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "NetIncomeLessParticipatingSecuritiesShareInEarnings", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail" ], "lang": { "en-us": { "role": { "totalLabel": "Net (loss) income, less participating securities' share in earnings", "documentation": "Net income less participating securities share in earnings.", "label": "Net Income Less Participating Securities Share In Earnings" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss)", "terseLabel": "Net Income (Loss)", "totalLabel": "Net (loss) income attributable to MPT common stockholders (Operating Partnership partners)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r116", "r128", "r155", "r194", "r208", "r210", "r214", "r227", "r236", "r238", "r239", "r240", "r241", "r244", "r245", "r255", "r265", "r273", "r277", "r279", "r318", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r461", "r471", "r572", "r639", "r656", "r657", "r726", "r764", "r898" ] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Non-controlling interests' share in earnings", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "totalLabel": "Net Income (Loss) Attributable to Noncontrolling Interest, Total", "negatedLabel": "Net income attributable to non-controlling interests", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r85", "r142", "r208", "r210", "r244", "r245", "r571", "r865" ] }, "us-gaap_NetInvestmentInLease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetInvestmentInLease", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Net Investment in Lease, before Allowance for Credit Loss", "terseLabel": "Investment in financing leases", "totalLabel": "Total investment in financing leases", "documentation": "Amount, before allowance for credit loss, of net investment in sales-type and direct financing leases." } } }, "auth_ref": [ "r172", "r328", "r487", "r892" ] }, "mpw_NetInvestmentInRealEstateAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "NetInvestmentInRealEstateAssets", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Net Investment In Real Estate Assets", "label": "Net Investment In Real Estate Assets", "totalLabel": "Net investment in real estate assets" } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Recent Accounting Developments", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "mpw_NonCashImpairmentCharge": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "NonCashImpairmentCharge", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash impairment charge", "label": "Non-cash Impairment Charge", "documentation": "Non-cash impairment charge." } } }, "auth_ref": [] }, "mpw_NonCashRevenueFromDebtAndEquitySecuritiesReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "NonCashRevenueFromDebtAndEquitySecuritiesReceived", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Non-cash revenue from debt and equity securities received", "label": "Non Cash Revenue From Debt And Equity Securities Received", "documentation": "Non-cash revenue from debt and equity securities received." } } }, "auth_ref": [] }, "mpw_NonCashStraightLineRentWriteOffs": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "NonCashStraightLineRentWriteOffs", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2024ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash straight-line rent write-offs", "label": "Non-cash Straight-line Rent Write-offs", "documentation": "Non-cash straight-line rent write-offs." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]", "terseLabel": "Non-GAAP Measure Description" } } }, "auth_ref": [ "r809" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-NEOs [Member]", "terseLabel": "Non-NEOs" } } }, "auth_ref": [ "r779", "r790", "r800", "r817", "r825" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount", "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r807" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount", "terseLabel": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r806" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO [Member]", "terseLabel": "Non-PEO NEO" } } }, "auth_ref": [ "r817" ] }, "mpw_NonRealEstateInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "NonRealEstateInvestments", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-real estate investments", "label": "Non Real Estate Investments", "documentation": "Non Real Estate Investments" } } }, "auth_ref": [] }, "mpw_NonRule10B51ArrModifiedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "NonRule10B51ArrModifiedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non Rule 10b51 Arr Modified Flag", "documentation": "Non rule 10b51 arr modified flag." } } }, "auth_ref": [] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r836" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r836" ] }, "us-gaap_NonUsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonUsMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total International [Member]", "label": "Non-US [Member]", "documentation": "Countries excluding the United States of America (US)." } } }, "auth_ref": [ "r937", "r939", "r940", "r942" ] }, "us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of non-controlling interests", "label": "Noncontrolling Interest, Increase from Subsidiary Equity Issuance", "documentation": "Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders." } } }, "auth_ref": [ "r17", "r62", "r141" ] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest [Member]", "terseLabel": "Non-Controlling Interests [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r69", "r377", "r878", "r879", "r880", "r935" ] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total other expense", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r122" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other expense", "label": "Nonoperating Income (Expense) [Abstract]" } } }, "auth_ref": [] }, "mpw_NumberOfAncillaryFacilitiesSold": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "NumberOfAncillaryFacilitiesSold", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2024ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Number of ancillary facilities sold", "label": "Number Of Ancillary Facilities Sold", "documentation": "Number of ancillary facilities sold." } } }, "auth_ref": [] }, "us-gaap_NumberOfBusinessesAcquired": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfBusinessesAcquired", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Number of Businesses Acquired", "terseLabel": "Number of facilities acquired", "documentation": "The number of businesses acquired by the entity during the period." } } }, "auth_ref": [] }, "us-gaap_NumberOfCountriesInWhichEntityOperates": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfCountriesInWhichEntityOperates", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Number of Countries in which Entity Operates", "terseLabel": "Number of countries", "documentation": "The number of countries in which the entity operates as of balance sheet date." } } }, "auth_ref": [] }, "mpw_NumberOfDirectFinancingLeases": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "NumberOfDirectFinancingLeases", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Number of direct financing leases.", "label": "Number Of Direct Financing Leases", "terseLabel": "Number of direct financing leases" } } }, "auth_ref": [] }, "mpw_NumberOfFacilities": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "NumberOfFacilities", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Number of facilities.", "label": "Number Of Facilities", "terseLabel": "Number of facilities" } } }, "auth_ref": [] }, "mpw_NumberOfFacilitiesAcquired": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "NumberOfFacilitiesAcquired", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Number of facilities acquired", "label": "Number Of Facilities Acquired", "documentation": "Number of facilities acquired," } } }, "auth_ref": [] }, "mpw_NumberOfFacilitiesHeldForSale": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "NumberOfFacilitiesHeldForSale", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherUpdatesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of Facilities Held For Sale.", "label": "Number Of Facilities Held For Sale", "terseLabel": "Number of facilites agreed to sell" } } }, "auth_ref": [] }, "mpw_NumberOfFacilitiesSold": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "NumberOfFacilitiesSold", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2024ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Number of facilities sold.", "label": "Number Of Facilities Sold", "terseLabel": "Number of facilities sold" } } }, "auth_ref": [] }, "mpw_NumberOfFinancingLeases": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "NumberOfFinancingLeases", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Number of financing leases.", "label": "Number Of Financing Leases", "terseLabel": "Number of financing leases" } } }, "auth_ref": [] }, "mpw_NumberOfLeasedFacilities": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "NumberOfLeasedFacilities", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Number of leased facilities", "label": "Number Of Leased Facilities", "documentation": "Number of leased facilities." } } }, "auth_ref": [] }, "mpw_NumberOfLeasedProperties": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "NumberOfLeasedProperties", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of leased properties.", "label": "Number Of Leased Properties", "terseLabel": "Number of leased properties" } } }, "auth_ref": [] }, "mpw_NumberOfMarkets": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "NumberOfMarkets", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of markets", "label": "Number Of Markets", "documentation": "Number of markets." } } }, "auth_ref": [] }, "mpw_NumberOfOtherDevelopmentProjects": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "NumberOfOtherDevelopmentProjects", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Number of other development projects", "label": "Number Of Other Development Projects", "documentation": "Number of other development projects." } } }, "auth_ref": [] }, "mpw_NumberOfOtherDomesticProperty": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "NumberOfOtherDomesticProperty", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherUpdatesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of other domestic property", "label": "Number of Other Domestic Property", "documentation": "Number of other domestic property." } } }, "auth_ref": [] }, "mpw_NumberOfProperties": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "NumberOfProperties", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Number of Properties", "label": "Number Of Properties", "terseLabel": "Number of properties" } } }, "auth_ref": [] }, "mpw_NumberOfPropertiesLeased": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "NumberOfPropertiesLeased", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of properties leased", "label": "Number Of Properties Leased", "documentation": "Number of properties leased." } } }, "auth_ref": [] }, "mpw_NumberOfPropertiesNotTransitionedToNewOperators": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "NumberOfPropertiesNotTransitionedToNewOperators", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of properties not transitioned to new operators", "label": "Number Of Properties Not Transitioned To New Operators", "documentation": "Number Of Properties Not Transitioned To New Operators" } } }, "auth_ref": [] }, "mpw_NumberOfPropertiesSold": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "NumberOfPropertiesSold", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2024ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Number of properties sold.", "label": "Number Of Properties Sold", "terseLabel": "Number of properties sold" } } }, "auth_ref": [] }, "mpw_NumberOfPropertiesVacant": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "NumberOfPropertiesVacant", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of properties vacant", "label": "Number of Properties Vacant", "documentation": "Number of properties vacant." } } }, "auth_ref": [] }, "us-gaap_NumberOfRealEstateProperties": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfRealEstateProperties", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of properties", "label": "Number of Real Estate Properties", "documentation": "The number of real estate properties owned as of the balance sheet date." } } }, "auth_ref": [] }, "mpw_NumberOfRemainingFacilitiesSold": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "NumberOfRemainingFacilitiesSold", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Number of remaining facilities sold", "label": "Number of Remaining Facilities Sold", "documentation": "Number of remaining facilities sold." } } }, "auth_ref": [] }, "us-gaap_NumberOfStatesInWhichEntityOperates": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfStatesInWhichEntityOperates", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Number of States in which Entity Operates", "terseLabel": "Number of states", "documentation": "The number of states the entity operates in as of the balance sheet date." } } }, "auth_ref": [] }, "mpw_NumberOfUtahHospitalsSold": { "xbrltype": "integerItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "NumberOfUtahHospitalsSold", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Utah hospitals sold", "label": "Number Of Utah Hospitals Sold", "documentation": "Number Of Utah Hospitals Sold" } } }, "auth_ref": [] }, "stpr_OH": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "OH", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "OHIO", "terseLabel": "Ohio [Member]" } } }, "auth_ref": [] }, "mpw_ObligationsToTenantsAndOtherLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "ObligationsToTenantsAndOtherLeaseLiabilities", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Obligations to tenants and other lease liabilities.", "label": "Obligations To Tenants And Other Lease Liabilities", "terseLabel": "Obligations to tenants and other lease liabilities" } } }, "auth_ref": [] }, "mpw_OperatorConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "OperatorConcentrationRiskMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "documentation": "Operator concentration risk.", "label": "Operator Concentration Risk [Member]", "terseLabel": "Operator Concentration Risk [Member]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureOrganization" ], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "Organization", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r101", "r139", "r588", "r589" ] }, "us-gaap_OtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssets", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other Assets", "totalLabel": "Total other assets", "terseLabel": "Other assets,net", "verboseLabel": "Other assets", "documentation": "Amount of assets classified as other." } } }, "auth_ref": [ "r145", "r196", "r559", "r766" ] }, "mpw_OtherAssetsByFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "OtherAssetsByFacilityMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "Other Assets By Facility [Member]", "documentation": "Other assets by facility." } } }, "auth_ref": [] }, "mpw_OtherAssetsByOperatorMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "OtherAssetsByOperatorMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Other Assets by Operator [Member]", "documentation": "Other assets by operator." } } }, "auth_ref": [] }, "us-gaap_OtherAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Assets [Member]", "label": "Other Assets [Member]", "documentation": "Primary financial statement caption encompassing other assets." } } }, "auth_ref": [ "r87", "r90" ] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20240331/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveLossIncomeUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Foreign currency translation gain", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax", "terseLabel": "Foreign currency translation (loss) gain", "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r5", "r113", "r472", "r473", "r476" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveLossIncomeUnaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Reclassification of interest rate swap gain from AOCI, net of tax", "negatedLabel": "Reclassification of interest rate swap gain from AOCI, net of tax", "terseLabel": "Reclassification of interest rate swap gain from AOCI, net of tax", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax", "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r203", "r206" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20240331/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveLossIncomeUnaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Reclassification of foreign currency translation loss to earnings", "verboseLabel": "Reclassification of foreign currency translation loss to earnings", "negatedLabel": "Reclassification of foreign currency translation loss from AOCI", "terseLabel": "Reclassification of foreign currency translation loss from AOCI", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax", "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation." } } }, "auth_ref": [ "r6", "r7", "r113", "r207", "r475" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveLossIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive (loss) income:", "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]" } } }, "auth_ref": [] }, "mpw_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesNetOfTax", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20240331/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveLossIncomeUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Unrealized loss on interest rate swaps, net of tax", "documentation": "Other comprehensive income unrealized gain (loss) on derivatives net of tax.", "label": "Other Comprehensive Income Unrealized Gain Loss On Derivatives Net Of Tax", "terseLabel": "Unrealized (loss) gain on interest rate swaps, net of tax" } } }, "auth_ref": [] }, "mpw_OtherDomesticAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "OtherDomesticAssetsMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Domestic Assets [Member]", "label": "Other Domestic Assets [Member]", "documentation": "Other domestic assets." } } }, "auth_ref": [] }, "mpw_OtherFinancingLeasesNetOfAllowanceForCreditLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "OtherFinancingLeasesNetOfAllowanceForCreditLoss", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesComponentsOfTotalInvestmentInFinancingLeasesDetail" ], "lang": { "en-us": { "role": { "documentation": "Other financing leases, net of allowance for credit loss.", "label": "Other Financing Leases Net Of Allowance For Credit Loss", "terseLabel": "Other financing leases (net of allowance for credit loss)" } } }, "auth_ref": [] }, "mpw_OtherInternationalAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "OtherInternationalAssetsMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other International Assets [Member]", "label": "Other International Assets [Member]", "documentation": "Other international assets." } } }, "auth_ref": [] }, "mpw_OtherInvestmentOnSecuredLoanWithCreditFacilityCollateral": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "OtherInvestmentOnSecuredLoanWithCreditFacilityCollateral", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Other investment on secured loan with credit facility collateral.", "label": "Other Investment On Secured Loan with Credit Facility Collateral", "terseLabel": "Other investment on secured loan with credit facility collateral" } } }, "auth_ref": [] }, "mpw_OtherLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "OtherLoansMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "documentation": "Other Loans", "label": "Other Loans [Member]", "terseLabel": "Other Loans [Member]" } } }, "auth_ref": [] }, "us-gaap_OtherNoncashIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncashIncomeExpense", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Other adjustments (including fair value adjustments on securities)", "label": "Other Noncash Income (Expense)", "totalLabel": "Other Noncash Income (Expense), Total", "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other." } } }, "auth_ref": [ "r128" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesDesignatedAsHeldForSaleAndSoldDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Other expense", "label": "Other Nonoperating Income (Expense)", "totalLabel": "Other Nonoperating Income (Expense), Total", "terseLabel": "Other (including fair value adjustments on securities)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r123" ] }, "us-gaap_OtherNonoperatingIncomeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpenseMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Other Nonoperating Income (Expense) [Member]", "terseLabel": "Other [Member]", "documentation": "Primary financial statement caption encompassing other nonoperating income (expense)." } } }, "auth_ref": [] }, "mpw_OtherOperatorsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "OtherOperatorsMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Operators [Member]", "label": "Other Operators [Member]", "documentation": "Other operators." } } }, "auth_ref": [] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount", "terseLabel": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r809" ] }, "mpw_OtherTenantUpdatesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "OtherTenantUpdatesMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherUpdatesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Other tenant updates.", "label": "Other Tenant Updates [Member]" } } }, "auth_ref": [] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount", "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r777", "r788", "r798", "r823" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount", "terseLabel": "Compensation Amount" } } }, "auth_ref": [ "r780", "r791", "r801", "r826" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r780", "r791", "r801", "r826" ] }, "stpr_PA": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "PA", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Pennsylvania [Member]", "label": "PENNSYLVANIA" } } }, "auth_ref": [] }, "us-gaap_PartnerTypeOfPartnersCapitalAccountAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PartnerTypeOfPartnersCapitalAccountAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical" ], "lang": { "en-us": { "role": { "label": "Partner Type [Axis]", "terseLabel": "Partner Type", "documentation": "Information by type or class of partner's capital account. Examples of classes of partners include, but not limited to, general partners, limited partners, preferred partners, and other ownership interests." } } }, "auth_ref": [ "r63", "r597" ] }, "us-gaap_PartnerTypeOfPartnersCapitalAccountNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PartnerTypeOfPartnersCapitalAccountNameDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical" ], "lang": { "en-us": { "role": { "label": "Partner Type of Partners' Capital Account, Name [Domain]", "terseLabel": "Partner Type of Partners' Capital Account, Name", "documentation": "Capital accounts of each type or class of partner. Examples of classes of partners include, but are not limited to, general partners, limited partners, preferred partners, and other ownership interests." } } }, "auth_ref": [ "r138", "r597" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r805" ] }, "mpw_PayableDueToParentCompany": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "PayableDueToParentCompany", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Payable due to parent company", "label": "Payable Due To Parent Company", "terseLabel": "Payable due to Medical Properties Trust, Inc." } } }, "auth_ref": [] }, "mpw_PaydownOnDebtInstruments": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "PaydownOnDebtInstruments", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Pay down of debt instruments", "label": "Paydown On Debt Instruments", "documentation": "Paydown on debt instruments." } } }, "auth_ref": [] }, "mpw_PaymentsForCapitalAdditionsAndOtherInvestmentsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "PaymentsForCapitalAdditionsAndOtherInvestmentsNet", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "documentation": "Payments for capital additions and other investments net.", "label": "Payments For Capital Additions And Other Investments Net", "negatedLabel": "Capital additions and other investments, net" } } }, "auth_ref": [] }, "mpw_PaymentsForProceedsFromLeaseDepositsAndOtherObligationsToTenants": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "PaymentsForProceedsFromLeaseDepositsAndOtherObligationsToTenants", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "documentation": "Payments for proceeds from lease deposits and other obligations to tenants.", "label": "Payments For Proceeds From Lease Deposits And Other Obligations To Tenants", "negatedLabel": "Lease deposits and other obligations to tenants", "terseLabel": "Lease deposits and other obligations to tenants" } } }, "auth_ref": [] }, "us-gaap_PaymentsOfOrdinaryDividends": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfOrdinaryDividends", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends/Distributions paid", "label": "Payments of Ordinary Dividends", "totalLabel": "Payments of Ordinary Dividends, Total", "documentation": "Cash outflow in the form of ordinary dividends to common shareholders, preferred shareholders and noncontrolling interests, generally out of earnings." } } }, "auth_ref": [ "r38" ] }, "mpw_PaymentsOfPartialCashRent": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "PaymentsOfPartialCashRent", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Partial cash rent Payments", "label": "Payments of Partial Cash Rent", "documentation": "Payments of partial cash rent." } } }, "auth_ref": [] }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Stock vesting/Unit vesting - satisfaction of tax withholdings", "label": "Payment, Tax Withholding, Share-Based Payment Arrangement", "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [ "r221" ] }, "us-gaap_PaymentsToAcquireBusinessesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireBusinessesGross", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Payment for acquisition", "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price." } } }, "auth_ref": [ "r36", "r442" ] }, "us-gaap_PaymentsToAcquireLoansReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireLoansReceivable", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Loans Receivable", "terseLabel": "Investment in loans receivable", "negatedLabel": "Investment in loans receivable", "documentation": "The cash outflow for the purchase of loan receivable arising from the financing of goods and services." } } }, "auth_ref": [ "r35" ] }, "us-gaap_PaymentsToAcquireRealEstate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireRealEstate", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Payments to Acquire Real Estate", "negatedLabel": "Cash paid for acquisitions and other related investments", "totalLabel": "Payments to Acquire Real Estate, Total", "documentation": "The cash outflow from the acquisition of a piece of land, anything permanently fixed to it, including buildings, structures on it and so forth; includes real estate intended to generate income for the owner; excludes real estate acquired for use by the owner." } } }, "auth_ref": [ "r125" ] }, "us-gaap_PaymentsToFundLongtermLoansToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToFundLongtermLoansToRelatedParties", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loan facility funded shares", "label": "Payments to Fund Long-Term Loans to Related Parties", "documentation": "The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates." } } }, "auth_ref": [ "r869", "r913" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]", "terseLabel": "Peer Group Issuers, Footnote" } } }, "auth_ref": [ "r808" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount", "terseLabel": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r808" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount", "terseLabel": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r807" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO [Member]", "terseLabel": "PEO" } } }, "auth_ref": [ "r817" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name", "terseLabel": "PEO Name" } } }, "auth_ref": [ "r810" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount", "terseLabel": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r806" ] }, "mpw_PercentageOfAssetsAgreedToSell": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "PercentageOfAssetsAgreedToSell", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherUpdatesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of assets agreed to sell.", "label": "Percentage Of Assets Agreed To Sell", "terseLabel": "Percentage of total asstes held for sale" } } }, "auth_ref": [] }, "mpw_PercentageOfAssetsRepresentingPropertiesLeasedAndLoanToInternationJointVentures": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "PercentageOfAssetsRepresentingPropertiesLeasedAndLoanToInternationJointVentures", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherUpdatesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of assets representing properties leased and loan to internation joint ventures", "label": "Percentage of Assets Representing Properties Leased and Loan to Internation Joint Ventures", "documentation": "Percentage of assets representing properties leased and loan to internation joint ventures." } } }, "auth_ref": [] }, "mpw_PercentageOfDeferedRentReceivable": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "PercentageOfDeferedRentReceivable", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of defered rent", "label": "Percentage of Defered Rent Receivable", "documentation": "Percentage of defered rent receivable." } } }, "auth_ref": [] }, "mpw_PercentageOfDividendsPayableOnBasisOfAdjustedOperatingFunds": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "PercentageOfDividendsPayableOnBasisOfAdjustedOperatingFunds", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtCovenantsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Percentage of dividends payable on basis of adjusted operating funds.", "label": "Percentage Of Dividends Payable On Basis Of Adjusted Operating Funds", "terseLabel": "Percentage of dividends which could be paid from adjusted operating funds" } } }, "auth_ref": [] }, "mpw_PercentageOfDividendsPayableOnSeniorUnsecuredNotes": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "PercentageOfDividendsPayableOnSeniorUnsecuredNotes", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtCovenantsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Percentage of dividends payable on senior unsecured notes.", "label": "Percentage Of Dividends Payable On Senior Unsecured Notes", "terseLabel": "Percentage of dividends which could be paid from operation funds" } } }, "auth_ref": [] }, "mpw_PercentageOfInterestRetainedInVenture": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "PercentageOfInterestRetainedInVenture", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of interest retained in venture", "label": "Percentage Of Interest Retained In Venture", "documentation": "Percentage Of Interest Retained In Venture" } } }, "auth_ref": [] }, "mpw_PercentageOfInterestSoldInVenture": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "PercentageOfInterestSoldInVenture", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of interest sold in venture", "label": "Percentage Of Interest Sold In Venture", "documentation": "Percentage Of Interest Sold In Venture" } } }, "auth_ref": [] }, "mpw_PercentageOfLeasedAssetsOwned": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "PercentageOfLeasedAssetsOwned", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of leased assets owned", "label": "Percentage of Leased Assets Owned", "documentation": "Percentage of leased assets owned." } } }, "auth_ref": [] }, "mpw_PercentageOfPropertiesOccupiedByTenants": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "PercentageOfPropertiesOccupiedByTenants", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Percentage of properties occupied by tenants.", "label": "Percentage of Properties Occupied By Tenants", "terseLabel": "Percentage of properties occupied by tenants" } } }, "auth_ref": [] }, "mpw_PercentageOfVacantOnLeasedProperty": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "PercentageOfVacantOnLeasedProperty", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherLeasingActivitiesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of vacant on leased property", "label": "Percentage Of Vacant On Leased Property", "documentation": "Percentage of vacant on leased property." } } }, "auth_ref": [] }, "mpw_PhpHoldingsEquityInvestmentMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "PhpHoldingsEquityInvestmentMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "PHP Holdings Equity Investment [Member]", "label": "PHP Holdings Equity Investment [Member]", "documentation": "Php holdings equity investment." } } }, "auth_ref": [] }, "mpw_PhpHoldingsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "PhpHoldingsMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDlomBySensitivityAnalysisByUsingBasisPointVariationsDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "PHP Holdings [Member]", "documentation": "PHP Holdings [Member]" } } }, "auth_ref": [] }, "mpw_PipelineHealthSystemMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "PipelineHealthSystemMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Pipeline health system.", "label": "Pipeline Health System [Member]", "terseLabel": "Pipeline Health System [Member]" } } }, "auth_ref": [] }, "us-gaap_PledgingPurposeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PledgingPurposeAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "label": "Pledging Purpose [Axis]", "documentation": "Information by pledging purpose of pledged asset owned." } } }, "auth_ref": [ "r516", "r746", "r750", "r848" ] }, "us-gaap_PledgingPurposeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PledgingPurposeDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "label": "Pledging Purpose [Domain]", "documentation": "Pledging purpose of pledged asset owned." } } }, "auth_ref": [ "r516", "r746", "r750", "r848" ] }, "mpw_PoliclinicoDiMonzaMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "PoliclinicoDiMonzaMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails" ], "lang": { "en-us": { "role": { "documentation": "Policlinico di Monza.", "label": "Policlinico di Monza [Member]", "terseLabel": "Policlinico di Monza [Member]" } } }, "auth_ref": [] }, "mpw_PositiveHundredBasisPointsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "PositiveHundredBasisPointsMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDlomBySensitivityAnalysisByUsingBasisPointVariationsDetails" ], "lang": { "en-us": { "role": { "documentation": "Positive Hundred Basis Points.", "label": "Positive Hundred Basis Points [Member]", "terseLabel": "+ 100 Basis Points [Member]" } } }, "auth_ref": [] }, "us-gaap_PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "label": "Preferred Stock [Member]", "terseLabel": "Preferred Par Value [Member]", "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company." } } }, "auth_ref": [ "r752", "r753", "r756", "r757", "r758", "r759", "r931", "r935" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r106", "r374" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r106", "r619" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding", "periodStartLabel": "Preferred Stock, Shares Outstanding, Beginning Balance", "periodEndLabel": "Preferred Stock, Shares Outstanding, Ending Balance", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r106", "r619", "r637", "r935", "r936" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding", "totalLabel": "Preferred Stock, Value, Issued, Total", "periodStartLabel": "Preferred Stock, Value, Issued, Beginning Balance", "periodEndLabel": "Preferred Stock, Value, Issued, Ending Balance", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r106", "r562", "r749" ] }, "mpw_PrimeHealthCareServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "PrimeHealthCareServicesMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Prime Healthcare Services [Member]", "label": "Prime Health Care Services [Member]", "documentation": "Prime Health Care Services.", "verboseLabel": "Prime [Member]" } } }, "auth_ref": [] }, "mpw_PrimeHealthcareServicesIncFacilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "PrimeHealthcareServicesIncFacilitiesMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2024ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Prime Healthcare Services, Inc. Facilities [Member]", "documentation": "Prime Healthcare Services, Inc. facilities." } } }, "auth_ref": [] }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PriorPeriodReclassificationAdjustmentDescription", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Reclassification, Comparability Adjustment [Policy Text Block]", "terseLabel": "Reclassifications", "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error." } } }, "auth_ref": [ "r862" ] }, "mpw_PrioryGroupMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "PrioryGroupMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails" ], "lang": { "en-us": { "role": { "documentation": "Priory Group.", "label": "Priory Group [Member]", "terseLabel": "Priory Group [Member]", "verboseLabel": "Priory [Member]" } } }, "auth_ref": [] }, "mpw_ProceedFromSaleOfInterestInSyndicatedTermLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "ProceedFromSaleOfInterestInSyndicatedTermLoan", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Proceed from sale of interest in syndicated term loan", "label": "Proceed from Sale of Interest in Syndicated Term Loan", "documentation": "Proceed from sale of interest in syndicated term loan." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromDivestitureOfBusinesses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromDivestitureOfBusinesses", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from transaction", "label": "Proceeds from Divestiture of Businesses", "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period." } } }, "auth_ref": [ "r34" ] }, "us-gaap_ProceedsFromDivestitureOfInterestInJointVenture": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromDivestitureOfInterestInJointVenture", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from divestiture of interest in joint venture", "label": "Proceeds from Divestiture of Interest in Joint Venture", "documentation": "The cash inflow from the sale of an investment interest in a joint venture that the reporting entity has not previously accounted for using consolidation or the equity method of accounting." } } }, "auth_ref": [ "r34" ] }, "us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sale and return of equity investment", "label": "Proceeds from Equity Method Investment, Distribution, Return of Capital", "documentation": "Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities." } } }, "auth_ref": [ "r223", "r868" ] }, "us-gaap_ProceedsFromIssuanceOfSecuredDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfSecuredDebt", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Addition loan collateralized by equity", "label": "Proceeds from Issuance of Secured Debt", "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt." } } }, "auth_ref": [ "r37" ] }, "us-gaap_ProceedsFromLoanOriginations1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromLoanOriginations1", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2024ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from interest-bearing mortgage loan", "label": "Proceeds from Loan Originations", "documentation": "Cash inflow associated with loan origination (the process when securing a mortgage for a piece of real property) or lease origination." } } }, "auth_ref": [ "r32" ] }, "us-gaap_ProceedsFromLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromLoans", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Proceeds from Loans", "documentation": "Cash received from principal payments made on loans related to operating activities." } } }, "auth_ref": [ "r41" ] }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other financing activities, payment of debt refinancing, and deferred financing costs", "label": "Proceeds from (Payments for) Other Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities classified as other." } } }, "auth_ref": [ "r847", "r870" ] }, "us-gaap_ProceedsFromRentsReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRentsReceived", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Received rent", "label": "Proceeds from Rents Received", "documentation": "Cash received for rents during the current period." } } }, "auth_ref": [ "r40" ] }, "us-gaap_ProceedsFromRepaymentsOfLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRepaymentsOfLinesOfCredit", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving credit facility, net", "label": "Proceeds from (Repayments of) Lines of Credit", "totalLabel": "Proceeds from (Repayments of) Lines of Credit, Total", "documentation": "The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets)." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromSaleOfLoansReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfLoansReceivable", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds received from sale and repayment of loans receivable", "label": "Proceeds from Sale of Loans Receivable", "documentation": "The cash inflow associated with the sale of loans receivables arising from the financing of goods and services." } } }, "auth_ref": [ "r33" ] }, "us-gaap_ProceedsFromSaleOfOtherInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfOtherInvestments", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Proceeds from Sale of Other Investments", "terseLabel": "Sale of investment", "documentation": "Amount of cash inflow from the sale of investments classified as other." } } }, "auth_ref": [ "r846" ] }, "us-gaap_ProceedsFromSaleOfProductiveAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfProductiveAssets", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Proceeds from Sale of Productive Assets", "terseLabel": "Net proceeds from sale of real estate", "totalLabel": "Proceeds from Sale of Productive Assets, Total", "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets." } } }, "auth_ref": [ "r124" ] }, "us-gaap_ProceedsFromSaleOfRealEstate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfRealEstate", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2024ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Proceeds from Sale of Real Estate", "terseLabel": "Proceeds from sale of facilities", "totalLabel": "Proceeds from Sale of Real Estate, Total", "verboseLabel": "Expected cash proceeds on transaction close", "documentation": "Cash received for the sale of real estate that is not part of an investing activity during the current period." } } }, "auth_ref": [ "r124" ] }, "mpw_ProceedsReceivedToPaydownOutstandingLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "ProceedsReceivedToPaydownOutstandingLoan", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds received to paydown outstanding loan", "label": "Proceeds Received To Paydown Outstanding Loan", "documentation": "Proceeds received to paydown outstanding loan." } } }, "auth_ref": [] }, "mpw_ProceedsToPaydownOfActualOutstandingLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "ProceedsToPaydownOfActualOutstandingLoan", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds to paydown of actual outstanding loan", "label": "Proceeds To Paydown Of Actual Outstanding Loan", "documentation": "Proceeds to paydown of actual outstanding loan." } } }, "auth_ref": [] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited", "http://medicalpropertiestrust.com/20240331/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveLossIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Net (loss) income", "totalLabel": "Net (loss) income", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "verboseLabel": "Net (loss) income", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r194", "r208", "r210", "r222", "r227", "r236", "r244", "r245", "r265", "r273", "r277", "r279", "r318", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r444", "r447", "r448", "r461", "r471", "r556", "r570", "r595", "r639", "r656", "r657", "r726", "r747", "r748", "r765", "r865", "r898" ] }, "us-gaap_ProfitLossFromRealEstateOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLossFromRealEstateOperations", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2024ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Profit (loss) from real estate operations", "terseLabel": "Rental income", "documentation": "The net cost of operation of other real estate (including provisions for real estate losses, rental income, and gains and losses on sales of real estate)." } } }, "auth_ref": [ "r157" ] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Long-Lived Tangible Asset", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r11" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Long-Lived Tangible Asset", "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r132" ] }, "mpw_PropertyRelatedExpensesAndWriteOffStraightLineRent": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "PropertyRelatedExpensesAndWriteOffStraightLineRent", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesDesignatedAsHeldForSaleAndSoldDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property-related expenses", "label": "Property-related Expenses and Write-off Straight Line Rent", "documentation": "Property-related Expenses and Write-off Straight Line Rent" } } }, "auth_ref": [] }, "mpw_ProspectMedicalHoldingsIncMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "ProspectMedicalHoldingsIncMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Prospect Medical Holdings Inc.", "label": "Prospect Medical Holdings Inc [Member]", "terseLabel": "Prospect [Member]" } } }, "auth_ref": [] }, "mpw_ProspectMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "ProspectMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prospect [Member]", "label": "Prospect [Member]", "documentation": "Prospect." } } }, "auth_ref": [] }, "us-gaap_ProvisionForLoanLeaseAndOtherLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProvisionForLoanLeaseAndOtherLosses", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesCreditLossReservesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Provision for Loan, Lease, and Other Losses, Total", "label": "Provision for Loan, Lease, and Other Losses", "terseLabel": "Provision (recovery) for credit loss", "documentation": "Amount of expense related loan transactions, lease transactions, credit loss from transactions other than loan and lease transactions, and other loss based on assessment of uncollectability from the counterparty to reduce the account to their net realizable value." } } }, "auth_ref": [ "r9", "r15", "r156" ] }, "us-gaap_ProvisionForLoanLossesExpensed": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProvisionForLoanLossesExpensed", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfActivityInCreditLossReservesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Provision for credit loss, net", "label": "Financing Receivable, Credit Loss, Expense (Reversal)", "documentation": "Amount of credit loss expense (reversal of expense) for financing receivable." } } }, "auth_ref": [ "r325", "r551" ] }, "mpw_PurchaseOfNonControllingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "PurchaseOfNonControllingInterest", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "documentation": "Purchase of non controlling interest.", "label": "Purchase Of Non Controlling Interest", "terseLabel": "Acquisition of non-controlling interest" } } }, "auth_ref": [] }, "mpw_PurchaseOfNonControllingInterestOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "PurchaseOfNonControllingInterestOfShares", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "documentation": "Purchase Of Non Controlling Interest of shares", "label": "Purchase Of Non Controlling Interest Of Shares", "terseLabel": "Acquisition of Non-Controlling Interest (Shares)" } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r805" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]", "terseLabel": "Pay vs Performance Disclosure, Table" } } }, "auth_ref": [ "r805" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2024ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement", "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r342", "r343", "r344", "r345", "r381", "r389", "r418", "r419", "r420", "r507", "r534", "r580", "r609", "r610", "r664", "r670", "r673", "r674", "r692", "r715", "r716", "r727", "r735", "r743", "r751", "r754", "r895", "r902", "r918", "r919", "r920", "r921", "r922" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2024ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesLeasingOperationsLessorAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement", "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r342", "r343", "r344", "r345", "r381", "r389", "r418", "r419", "r420", "r507", "r534", "r580", "r609", "r610", "r664", "r670", "r673", "r674", "r692", "r715", "r716", "r727", "r735", "r743", "r751", "r754", "r895", "r902", "r918", "r919", "r920", "r921", "r922" ] }, "us-gaap_RealEstateAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateAbstract", "lang": { "en-us": { "role": { "label": "Real Estate [Abstract]" } } }, "auth_ref": [] }, "mpw_RealEstateAccumulatedDepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "RealEstateAccumulatedDepreciationAndAmortization", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Real estate accumulated depreciation and amortization.", "label": "Real Estate Accumulated Depreciation And Amortization", "negatedLabel": "Accumulated depreciation and amortization" } } }, "auth_ref": [] }, "mpw_RealEstateAndOtherImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "RealEstateAndOtherImpairmentCharges", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Real estate and other impairment charges, net", "verboseLabel": "Real estate and other impairment charges, net", "terseLabel": "Real estate and other impairment charges", "label": "Real Estate And Other Impairment Charges", "documentation": "Real estate and other impairment charges." } } }, "auth_ref": [] }, "mpw_RealEstateAndOtherImpairmentChargesRecovery": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "RealEstateAndOtherImpairmentChargesRecovery", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Real estate and other impairment charges, net", "documentation": "Real estate and other impairment charges (recovery).", "label": "Real Estate And Other Impairment Charges (Recovery)", "terseLabel": "Real estate and other impairment charges (recovery)" } } }, "auth_ref": [] }, "mpw_RealEstateAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "RealEstateAssetsAbstract", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Real Estate Assets [Abstract]", "label": "Real Estate Assets [Abstract]", "terseLabel": "Real estate assets" } } }, "auth_ref": [] }, "us-gaap_RealEstateDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateDisclosureTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivities" ], "lang": { "en-us": { "role": { "label": "Real Estate Disclosure [Text Block]", "terseLabel": "Real Estate and Other Activities", "documentation": "The entire disclosure for certain real estate investment financial statements, real estate investment trust operating support agreements, real estate owned, retail land sales, time share transactions, as well as other real estate related disclosures." } } }, "auth_ref": [ "r159", "r160", "r161", "r162", "r163" ] }, "us-gaap_RealEstateHeldforsale": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateHeldforsale", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Real Estate, Held-for-Sale", "terseLabel": "Real estate held for sale", "documentation": "Amount of investment in land and building held for sale. Excludes real estate considered inventory." } } }, "auth_ref": [ "r926" ] }, "us-gaap_RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Real Estate Investments, Unconsolidated Real Estate and Other Joint Ventures", "terseLabel": "Investments in unconsolidated real estate joint ventures", "documentation": "The carrying amount of investments in unconsolidated real estate and other joint ventures not separately presented. This includes direct and indirect investments." } } }, "auth_ref": [ "r926" ] }, "mpw_RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVenturesMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVenturesMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail" ], "lang": { "en-us": { "role": { "documentation": "Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures [Member]", "label": "Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures [Member]", "terseLabel": "Investments in Unconsolidated Real Estate Joint Ventures [Member]" } } }, "auth_ref": [] }, "us-gaap_ReceivablesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReceivablesAbstract", "lang": { "en-us": { "role": { "label": "Receivables [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ReceivablesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReceivablesFairValueDisclosure", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsDetail" ], "lang": { "en-us": { "role": { "label": "Receivables, Fair Value Disclosure", "terseLabel": "Interest and rent receivables, Fair value", "totalLabel": "Receivables, Fair Value Disclosure, Total", "documentation": "Fair value portion of receivables, including, but not limited to, trade account receivables, note receivables, and loan receivables." } } }, "auth_ref": [ "r152", "r908" ] }, "mpw_ReclassificationOfInterestRateSwapGainToEarningsNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "ReclassificationOfInterestRateSwapGainToEarningsNetOfTax", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassification of interest rate swap gain to earnings, net of tax", "label": "Reclassification Of Interest Rate Swap Gain To Earnings, Net Of Tax", "documentation": "Reclassification of interest rate swap gain to earnings, net of tax." } } }, "auth_ref": [] }, "mpw_ReconstitutionOfAssetRelatedToProspect": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "ReconstitutionOfAssetRelatedToProspect", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Reconstitution of asset", "label": "Reconstitution Of Asset Related To Prospect", "documentation": "Reconstitution of asset related to prospect." } } }, "auth_ref": [] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]", "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure" } } }, "auth_ref": [ "r772", "r783", "r793", "r818" ] }, "mpw_RedevelopmentOfRecoveryReceivablesOnDamageToTheOriginalFacility": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "RedevelopmentOfRecoveryReceivablesOnDamageToTheOriginalFacility", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Redevelopment of recovery receivables on damage to the original facility", "label": "Redevelopment Of Recovery Receivables On Damage to the Original Facility", "documentation": "Redevelopment of recovery receivables on damage to the original facility." } } }, "auth_ref": [] }, "mpw_RedevelopmentOfRecoveryReceivablesPriorStormAndFloodDamage": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "RedevelopmentOfRecoveryReceivablesPriorStormAndFloodDamage", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Redevelopment recovery receivables of prior storm and flood damage", "label": "Redevelopment Of Recovery Receivables Prior Storm and Flood Damage", "documentation": "Redevelopment of recovery receivables prior storm and flood damage." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Domain]", "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r388", "r494", "r495", "r613", "r614", "r615", "r616", "r617", "r636", "r638", "r661" ] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r388", "r494", "r495", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r613", "r614", "r615", "r616", "r617", "r636", "r638", "r661", "r914" ] }, "mpw_RemainingEquityInvestmentPercentage": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "RemainingEquityInvestmentPercentage", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "netLabel": "Remaining equity investment percentage", "label": "Remaining Equity Investment Percentage", "documentation": "Remaining equity investment percentage." } } }, "auth_ref": [] }, "mpw_RemainingOutstandingDeferredRentToBeReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "RemainingOutstandingDeferredRentToBeReceived", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesCoronavirusCovid19RentDeferralsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Remaining outstanding deferred rent to be received.", "label": "Remaining Outstanding Deferred Rent To Be Received", "terseLabel": "Remaining outstanding deferred rent to be received", "verboseLabel": "Percentage of deferred revenue lease" } } }, "auth_ref": [] }, "mpw_RentAndInterestObligationsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "RentAndInterestObligationsDue", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Rent and interest obligations due", "label": "Rent and Interest Obligations Due", "documentation": "Rent and interest obligations due." } } }, "auth_ref": [] }, "mpw_RentAndInterestObligationsPaidPercentage": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "RentAndInterestObligationsPaidPercentage", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Rent and interest obligations paid percentage", "label": "Rent And Interest Obligations Paid Percentage", "documentation": "Rent And Interest Obligations Paid Percentage" } } }, "auth_ref": [] }, "mpw_RentBilled": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "RentBilled", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "documentation": "Rent billed", "label": "Rent Billed", "terseLabel": "Rent billed" } } }, "auth_ref": [] }, "mpw_RentalRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "RentalRevenue", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "documentation": "Rental Revenue.", "label": "Rental Revenue", "terseLabel": "Rental revenue" } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfLongTermDebt", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Revolving credit facility amount paid", "label": "Repayments of Long-Term Debt", "negatedLabel": "Payments of term debt", "totalLabel": "Repayments of Long-term Debt, Total", "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r39", "r591" ] }, "mpw_RepaymentsOfMortgageLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "RepaymentsOfMortgageLoan", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Repayments of mortgage loan", "label": "Repayments Of Mortgage Loan", "documentation": "Repayments of mortgage loan." } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfOtherShortTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfOtherShortTermDebt", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Repayments of Other Short-Term Debt", "terseLabel": "Repayment received on credit facility availed", "documentation": "Amount of cash outflow for the payment of debt classified as other, maturing within one year or the operating cycle, if longer." } } }, "auth_ref": [ "r39" ] }, "mpw_RepaymentsOfRemainingShortTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "RepaymentsOfRemainingShortTermDebt", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Repayments of remaining short term debt.", "label": "Repayments Of Remaining Short Term Debt", "terseLabel": "Repayment received on credit facility availed, total amount" } } }, "auth_ref": [] }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RepurchaseAgreementCounterpartyNameDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]", "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution." } } }, "auth_ref": [ "r230", "r231", "r358", "r375", "r496", "r720", "r721" ] }, "mpw_ReservesOnStraightLineRentReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "ReservesOnStraightLineRentReceivables", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails" ], "lang": { "en-us": { "role": { "documentation": "Reserves on straight line rent receivables.", "label": "Reserves On Straight Line Rent Receivables", "terseLabel": "Reserves on straight line rent receivables" } } }, "auth_ref": [] }, "us-gaap_ResidualValueOfLeasedAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResidualValueOfLeasedAsset", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Residual Value of Leased Asset", "terseLabel": "Carrying value of lease requiring residual value guarantee", "totalLabel": "Residual Value of Leased Asset, Total", "documentation": "Amount of residual asset covered by residual value guarantee. Excludes guarantee considered to be lease payments for lessor." } } }, "auth_ref": [ "r492" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]", "terseLabel": "Restatement Determination Date:" } } }, "auth_ref": [ "r773", "r784", "r794", "r819" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date", "terseLabel": "Restatement Determination Date" } } }, "auth_ref": [ "r774", "r785", "r795", "r820" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]", "terseLabel": "Restatement does not require Recovery" } } }, "auth_ref": [ "r781", "r792", "r802", "r827" ] }, "us-gaap_RestrictedCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashAndCashEquivalents", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Restricted Cash and Cash Equivalents", "periodEndLabel": "Restricted cash, included in Other assets at end of period", "periodStartLabel": "Restricted cash, included in Other assets at beginning of period", "totalLabel": "Restricted Cash and Cash Equivalents, Total", "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r42", "r144", "r195", "r225", "r561" ] }, "us-gaap_RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashAndCashEquivalentsAssetStatementOfFinancialPositionExtensibleList", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Restricted Cash and Cash Equivalents, Statement of Financial Position [Extensible Enumeration]", "periodEndLabel": "Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]", "periodStartLabel": "Restricted Cash and Cash Equivalents, Asset, Statement of Financial Position [Extensible List]", "documentation": "Indicates line item in statement of financial position that includes cash and cash equivalents restricted to withdrawal or usage." } } }, "auth_ref": [ "r225" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Retained deficit", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Distributions in excess of net income", "totalLabel": "Retained Earnings (Accumulated Deficit), Total", "periodStartLabel": "Retained Earnings (Accumulated Deficit), Beginning Balance", "periodEndLabel": "Retained Earnings (Accumulated Deficit), Ending Balance", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r109", "r137", "r565", "r584", "r586", "r592", "r620", "r749" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Retained Deficit [Member]", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r191", "r233", "r234", "r235", "r237", "r243", "r245", "r319", "r320", "r426", "r427", "r428", "r434", "r435", "r452", "r454", "r455", "r457", "r459", "r581", "r583", "r596", "r935" ] }, "mpw_RevenueByFacilityTypeMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "RevenueByFacilityTypeMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "label": "Revenue by Facility Type [Member]", "documentation": "Revenue by facility type." } } }, "auth_ref": [] }, "mpw_RevenueForRentAndInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "RevenueForRentAndInterest", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue for rent and interest", "label": "Revenue For Rent and Interest", "documentation": "Revenue for rent and interest." } } }, "auth_ref": [] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Revenues", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesDesignatedAsHeldForSaleAndSoldDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Total Revenues", "label": "Revenues", "totalLabel": "Total revenues", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r216", "r227", "r266", "r267", "r272", "r275", "r276", "r280", "r281", "r283", "r318", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r471", "r556", "r898" ] }, "us-gaap_RevenuesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenuesAbstract", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Revenues" } } }, "auth_ref": [] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail" ], "lang": { "en-us": { "role": { "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility [Member]", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "mpw_Rule10B51ArrMofifiedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "Rule10B51ArrMofifiedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b51 Arr Mofified Flag", "documentation": "Rule 10b51 arr mofified flag." } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r836" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r836" ] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesRevenueNetMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Revenue Benchmark [Member]", "terseLabel": "Revenue [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r283", "r849" ] }, "srt_ScenarioForecastMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioForecastMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Forecast [Member]", "documentation": "Information reported for future period. Excludes information expected to be reported in future period for effect on historical fact." } } }, "auth_ref": [ "r390", "r858", "r881" ] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]", "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts." } } }, "auth_ref": [ "r246", "r390", "r844", "r881" ] }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesCreditLossReservesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]", "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables." } } }, "auth_ref": [ "r27" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesCoronavirusCovid19RentDeferralsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherUpdatesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesPipelineHealthSystemAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfOperatingResultsFromPropertiesDesignatedAsHeldForSaleAndSoldDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule Of Business Acquisitions By Acquisition [Table]", "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities." } } }, "auth_ref": [ "r65", "r66", "r441" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]", "terseLabel": "Net Assets Acquired", "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts." } } }, "auth_ref": [ "r65", "r66" ] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Debt [Table Text Block]", "terseLabel": "Summary of Debt", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "mpw_ScheduleOfDevelopmentProjectsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "ScheduleOfDevelopmentProjectsTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "lang": { "en-us": { "role": { "documentation": "Schedule of development projects.", "label": "Schedule Of Development Projects Table [Text Block]", "terseLabel": "Summary of Status on Current Development Projects" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareUnitTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Calculation of Earnings Per Share", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r882" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail" ], "lang": { "en-us": { "role": { "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]", "terseLabel": "Schedule Of Earnings Per Share Basic By Common Class [Table]", "documentation": "The table contains disclosure pertaining to an entity's basic earnings per share." } } }, "auth_ref": [ "r44", "r45", "r250", "r254", "r256" ] }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesProspectAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskParentheticalDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]", "documentation": "Information by name of investment including named security. Excludes entity that is consolidated." } } }, "auth_ref": [ "r315", "r316", "r317" ] }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Equity Method Investments [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r227", "r315", "r316", "r317", "r318", "r471" ] }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEquityMethodInvestmentsTable", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Equity Method Investments [Table]", "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available." } } }, "auth_ref": [ "r194", "r227", "r315", "r316", "r317", "r318", "r471" ] }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Equity Interest in Related Party and Related Loans Measured at Fair Value on Recurring Basis", "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r463", "r464" ] }, "us-gaap_ScheduleOfFinancingReceivableAllowanceForCreditLossesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFinancingReceivableAllowanceForCreditLossesTable", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfActivityInCreditLossReservesParentheticalDetails" ], "lang": { "en-us": { "role": { "label": "Financing Receivable, Allowance for Credit Loss [Table]", "documentation": "Disclosure of information about allowance for credit loss on financing receivable." } } }, "auth_ref": [ "r177", "r893" ] }, "us-gaap_ScheduleOfSensitivityAnalysisOfFairValueOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSensitivityAnalysisOfFairValueOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Sensitivity Analysis of Fair Value, Transferor's Interests in Transferred Financial Assets [Table Text Block]", "terseLabel": "Schedule of Effects of Movement in DLOM by Sensitivity Analysis by Using Basis Point Variations", "documentation": "Tabular disclosure of a sensitivity analysis or stress test showing the hypothetical effect on the fair value of the transferor's interests in transferred financial assets (including any servicing assets or servicing liabilities) of two or more unfavorable variations from the expected levels for each key assumption that is reported, independently determined from any change in another key assumption, and a description of the objectives, methodology, and limitations of the sensitivity analysis or stress test." } } }, "auth_ref": [ "r923" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r392", "r393", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421" ] }, "us-gaap_ScheduleOfVariableInterestEntitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfVariableInterestEntitiesTable", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Variable Interest Entities [Table]", "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide." } } }, "auth_ref": [ "r74", "r75", "r79", "r81", "r83", "r445", "r446", "r449", "r450", "r515", "r516", "r517" ] }, "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfVariableInterestEntitiesTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Carrying Value and Classification of the Assets and Maximum Exposure", "label": "Schedule of Variable Interest Entities [Table Text Block]", "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide." } } }, "auth_ref": [ "r74", "r75", "r79", "r81", "r83" ] }, "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Concentrations of Credit Risk", "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]", "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark." } } }, "auth_ref": [ "r46", "r47", "r50", "r51", "r93", "r143" ] }, "mpw_SecuredTermLoanDueTwoThousandTwentyFourMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "SecuredTermLoanDueTwoThousandTwentyFourMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Secured term loan due 2024", "label": "Secured Term Loan Due Two Thousand Twenty Four [Member]", "documentation": "Secured term loan due two thousand twenty four." } } }, "auth_ref": [] }, "mpw_SecuredTermLoanFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "SecuredTermLoanFacilityMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Secured Term Loan Facility", "label": "Secured Term Loan Facility [Member]", "documentation": "Secured term loan facility." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r767" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r769" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical", "documentation": "Geographical area." } } }, "auth_ref": [ "r179", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r281", "r282", "r601", "r604", "r606", "r665", "r671", "r678", "r695", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713", "r717", "r736", "r754", "r904", "r929" ] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Stock/Unit-based compensation expense", "verboseLabel": "Unit-based compensation", "label": "Share-Based Payment Arrangement, Noncash Expense", "totalLabel": "Share-based Payment Arrangement, Noncash Expense, Total", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r9" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r392", "r393", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Reserved shares of new common stock for awards under the Equity Incentive Plan", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized", "documentation": "Number of shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r745" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock remaining for future stock awards transferred to the equity incentive plan", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant", "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable." } } }, "auth_ref": [ "r64" ] }, "mpw_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantWithCashSettlement": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantWithCashSettlement", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Value of common stock granted with cash settlement feature", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Shares Available For Grant With Cash Settlement", "documentation": "Share-based compensation arrangement by share-based payment award, number of shares available for grant with cash settlement." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Incremental expense of stock awards", "label": "Share-Based Payment Arrangement, Plan Modification, Incremental Cost", "documentation": "An excess of the fair value of the modified award over the fair value of the award immediately before the modification." } } }, "auth_ref": [ "r424" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureStockAwardsAdditionalInformationDetail", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "All Award Types", "terseLabel": "All Award Types", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421" ] }, "mpw_ShareholderLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "ShareholderLoanMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Shareholder Loan.", "label": "Shareholder Loan [Member]" } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "label": "Shares, Outstanding", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r129", "r226" ] }, "srt_SouthAmericaMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SouthAmericaMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "South America [Member]", "terseLabel": "South America [Member]", "documentation": "Continent of South America." } } }, "auth_ref": [ "r937", "r939", "r940", "r942" ] }, "mpw_SpringstoneHealthOpcoLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "SpringstoneHealthOpcoLlcMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesNetAssetsAcquiredParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Springstone Health Opco, LLC [Member]", "label": "Springstone Health Opco, LLC [Member]", "documentation": "Springstone Health Opco, LLC." } } }, "auth_ref": [] }, "mpw_SpringstoneIncAndInternationalJointVentureMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "SpringstoneIncAndInternationalJointVentureMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Springstone Inc and International Joint Venture [Member]", "label": "Springstone Inc And International Joint Venture [Member]", "documentation": "Springstone inc and international joint venture." } } }, "auth_ref": [] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "terseLabel": "Equity Components", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r19", "r26", "r191", "r212", "r213", "r214", "r233", "r234", "r235", "r237", "r243", "r245", "r264", "r319", "r320", "r377", "r426", "r427", "r428", "r434", "r435", "r452", "r453", "r454", "r455", "r456", "r457", "r459", "r477", "r478", "r479", "r480", "r481", "r482", "r493", "r581", "r582", "r583", "r596", "r658" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedRealEstateJointVenturesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsSummaryOfFairValueInformationOfFinancialInstrumentsParentheticalDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureOrganizationAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical", "documentation": "Information by geographical components." } } }, "auth_ref": [ "r179", "r189", "r281", "r282", "r601", "r604", "r606", "r665", "r671", "r678", "r695", "r702", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713", "r717", "r736", "r754", "r904", "r929" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited", "http://medicalpropertiestrust.com/20240331/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveLossIncomeUnaudited" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r233", "r234", "r235", "r264", "r536", "r590", "r598", "r611", "r613", "r614", "r615", "r616", "r617", "r619", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r632", "r633", "r634", "r635", "r636", "r638", "r640", "r641", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r658", "r755" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementScenarioAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]", "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts." } } }, "auth_ref": [ "r246", "r390", "r844", "r845", "r881" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapitalParenthetical", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited", "http://medicalpropertiestrust.com/20240331/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveLossIncomeUnaudited" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "terseLabel": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r233", "r234", "r235", "r264", "r536", "r590", "r598", "r611", "r613", "r614", "r615", "r616", "r617", "r619", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r632", "r633", "r634", "r635", "r636", "r638", "r640", "r641", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r658", "r755" ] }, "mpw_StewardAndInternationalJointVentureMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "StewardAndInternationalJointVentureMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Steward and International Joint Venture [Member]", "label": "Steward and International Joint Venture [Member]", "documentation": "Steward and International Joint Venture." } } }, "auth_ref": [] }, "mpw_StewardEquityInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "StewardEquityInterestMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Steward Equity Investment [Member]", "label": "Steward Equity Investment [Member]", "documentation": "Steward Equity Investment." } } }, "auth_ref": [] }, "mpw_StewardHealthCareSystemLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "StewardHealthCareSystemLLCMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfActivityInCreditLossReservesParentheticalDetails" ], "lang": { "en-us": { "role": { "documentation": "Steward Health Care System LLC.", "label": "Steward Health Care System L L C [Member]", "terseLabel": "Steward Health Care System LLC [Member]", "verboseLabel": "Steward [Member]" } } }, "auth_ref": [] }, "mpw_StewardLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "StewardLoanMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Steward Loan Investment [Member]", "documentation": "Steward Loan Investment." } } }, "auth_ref": [] }, "mpw_StewardMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "StewardMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Steward (Macquarie partnership) [Member]", "terseLabel": "Steward [Member]", "label": "Steward [Member]", "documentation": "Steward." } } }, "auth_ref": [] }, "mpw_StewardsEquityMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "StewardsEquityMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Steward's Equity [Member]", "label": "Steward's Equity [Member]", "documentation": "Steward's equity." } } }, "auth_ref": [] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]", "terseLabel": "Stock Price or TSR Estimation Method" } } }, "auth_ref": [ "r776", "r787", "r797", "r822" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Appreciation Rights (SARs) [Member]", "terseLabel": "Stock Appreciation Rights (SARs)", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "mpw_StockIssuedDuringPeriodSharesStockVestingAndAmortizationOfStockBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "StockIssuedDuringPeriodSharesStockVestingAndAmortizationOfStockBasedCompensation", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "documentation": "Stock issued during period, shares, stock vesting and amortization of stock-based compensation.", "label": "Stock Issued During Period Shares Stock Vesting And Amortization Of Stock Based Compensation", "terseLabel": "Stock (Unit) vesting and amortization of stock (unit)-based compensation (shares)" } } }, "auth_ref": [] }, "mpw_StockIssuedDuringPeriodValueStockVestingAndAmortizationOfStockBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "StockIssuedDuringPeriodValueStockVestingAndAmortizationOfStockBasedCompensation", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "documentation": "Stock issued during period value stock vesting and amortization of stock based compensation.", "label": "Stock Issued During Period Value Stock Vesting And Amortization Of Stock Based Compensation", "terseLabel": "Stock (Unit) vesting and amortization of stock (unit)-based compensation" } } }, "auth_ref": [] }, "mpw_StockIssuedDuringPeriodValueStockVestingSatisfactionOfTaxWithholding": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "StockIssuedDuringPeriodValueStockVestingSatisfactionOfTaxWithholding", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "documentation": "Stock issued during period value stock vesting satisfaction of tax withholding.", "label": "Stock Issued During Period Value Stock Vesting Satisfaction Of Tax Withholding", "terseLabel": "Stock vesting - satisfaction of tax withholding", "negatedLabel": "Stock vesting - satisfaction of tax withholding" } } }, "auth_ref": [] }, "mpw_StockIssuedDuringPeriodValueStockVestingSatisfactionOfTaxWithholdingShares": { "xbrltype": "sharesItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "StockIssuedDuringPeriodValueStockVestingSatisfactionOfTaxWithholdingShares", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period Value Stock Vesting Satisfaction Of Tax Withholding shares", "label": "Stock Issued During Period Value Stock Vesting Satisfaction Of Tax Withholding Shares", "terseLabel": "Stock vesting - satisfaction of tax withholding (Shares)", "negatedLabel": "Stock vesting - satisfaction of tax withholding (Shares)" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Equity, Attributable to Parent", "totalLabel": "Total Medical Properties Trust, Inc. Stockholders' Equity (MPT Operating Partnership, L.P. capital)", "periodStartLabel": "Stockholders' Equity Attributable to Parent, Beginning Balance", "periodEndLabel": "Stockholders' Equity Attributable to Parent, Ending Balance", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r107", "r110", "r111", "r130", "r621", "r637", "r659", "r660", "r749", "r766", "r875", "r891", "r909", "r935" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfEquityCapital" ], "lang": { "en-us": { "role": { "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total Equity / Capital", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r69", "r70", "r84", "r191", "r192", "r213", "r233", "r234", "r235", "r237", "r243", "r319", "r320", "r377", "r426", "r427", "r428", "r434", "r435", "r452", "r453", "r454", "r455", "r456", "r457", "r459", "r477", "r478", "r482", "r493", "r582", "r583", "r594", "r621", "r637", "r659", "r660", "r701", "r765", "r875", "r891", "r909", "r935" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Equity / Capital" } } }, "auth_ref": [] }, "mpw_StraightLineRentAndOtherWriteOff": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "StraightLineRentAndOtherWriteOff", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Straight-line rent and other write-off", "label": "Straight-line Rent And Other Write-off", "documentation": "Straight-line rent and other write-off." } } }, "auth_ref": [] }, "mpw_StraightLineRentReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "StraightLineRentReceivable", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "documentation": "Straight-line rent receivable", "label": "Straight Line Rent Receivable", "terseLabel": "Straight-line rent receivables" } } }, "auth_ref": [] }, "mpw_StraightLineRentReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "StraightLineRentReceivables", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherUpdatesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Straight-line rent receivable writeoffs", "terseLabel": "Straight-line rent receivables", "label": "Straight-Line Rent Receivables", "documentation": "Straight-line rent receivables." } } }, "auth_ref": [] }, "mpw_StraightLineRentRevenueAndOther": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "StraightLineRentRevenueAndOther", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "documentation": "Straight-line rent revenue and other.", "label": "Straight Line Rent Revenue And Other", "negatedLabel": "Straight-line rent revenue and other" } } }, "auth_ref": [] }, "mpw_StraightLineRentRevenueNetOfWriteOffs": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "StraightLineRentRevenueNetOfWriteOffs", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "documentation": "Straight line rent revenue net of write offs.", "label": "Straight Line Rent Revenue Net Of Write Offs", "terseLabel": "Straight-line rent" } } }, "auth_ref": [] }, "mpw_StraightLineRentWriteOffs": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "StraightLineRentWriteOffs", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Straight-line rent write-offs", "documentation": "straight-line rent write-offs.", "label": "straight-Line Rent Write-Offs" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventLineItems", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r483", "r499" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtCovenantsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event", "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r483", "r499" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTable", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Table]", "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued." } } }, "auth_ref": [ "r483", "r499" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtCovenantsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r483", "r499" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDisposals2023ActivityAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtCovenantsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r483", "r499" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEvents1" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Events", "label": "Subsequent Events [Text Block]", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r498", "r500" ] }, "mpw_SummaryOfCreditLossReservesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "SummaryOfCreditLossReservesTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "lang": { "en-us": { "role": { "documentation": "Summary of credit loss reserves.", "label": "Summary Of Credit Loss Reserves [Table Text Block]", "terseLabel": "Summary of Activity in Credit Loss reserves" } } }, "auth_ref": [] }, "mpw_SummaryOfInvestmentsInUnconsolidatedOperatingEntitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "SummaryOfInvestmentsInUnconsolidatedOperatingEntitiesTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Investments in Unconsolidated Operating Entities", "documentation": "Summary of investments in unconsolidated operating entities.", "label": "Summary Of Investments In Unconsolidated Operating Entities [Table Text Block]" } } }, "auth_ref": [] }, "mpw_SummaryOfOperatingResultsFromPropertiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "SummaryOfOperatingResultsFromPropertiesTableTextBlock", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesTables" ], "lang": { "en-us": { "role": { "documentation": "Summary of Operating results from properties.", "label": "Summary Of Operating Results From Properties [Table Text Block]", "terseLabel": "Summary of Operating Results from Properties" } } }, "auth_ref": [] }, "mpw_SupplementalScheduleOfNonCashFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "SupplementalScheduleOfNonCashFinancingActivitiesAbstract", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "documentation": "Supplemental Schedule Of Non Cash Financing Activities [Abstract]", "label": "Supplemental Schedule Of Non Cash Financing Activities [Abstract]", "terseLabel": "Supplemental schedule of non-cash financing activities:" } } }, "auth_ref": [] }, "mpw_SwissMedicalNetworkMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "SwissMedicalNetworkMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedOperatingEntitiesDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesSummaryOfInvestmentsInUnconsolidatedRealEstateJointVenturesByOperatorDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Swiss medical network.", "label": "Swiss Medical Network [Member]", "terseLabel": "Swiss Medical Network [Member]" } } }, "auth_ref": [] }, "mpw_SyndicatedTermLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "SyndicatedTermLoanMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Syndicated Term Loan [Member]", "documentation": "Syndicated term loan." } } }, "auth_ref": [] }, "stpr_TX": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "TX", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesAlectoHealthcareServicesLlcAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesSummaryOfStatusOnCurrentDevelopmentProjectsDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Texas [Member]", "label": "TEXAS" } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]", "terseLabel": "Tabular List, Table" } } }, "auth_ref": [ "r816" ] }, "mpw_TaxRateChanges": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "TaxRateChanges", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Tax rate changes and other", "label": "Tax rate changes", "documentation": "Tax rate changes" } } }, "auth_ref": [] }, "mpw_TermLoanDueTwoThousandTwentyFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "TermLoanDueTwoThousandTwentyFiveMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail" ], "lang": { "en-us": { "role": { "verboseLabel": "Term loan due 2025 [Member]", "terseLabel": "Term loan due 2025", "label": "Term Loan Due Two Thousand Twenty Five [Member]", "documentation": "Term loan due two thousand twenty five." } } }, "auth_ref": [] }, "mpw_TermLoanDueTwoThousandTwentyFourMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "TermLoanDueTwoThousandTwentyFourMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term loan due 2024 [Member]", "label": "Term Loan Due Two Thousand Twenty Four [Member]", "documentation": "Term loan due two thousand twenty four." } } }, "auth_ref": [] }, "mpw_TermLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "TermLoanMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail" ], "lang": { "en-us": { "role": { "documentation": "Term loan.", "label": "Term Loan [Member]", "terseLabel": "Term Loan [Member]" } } }, "auth_ref": [] }, "mpw_TermLoanPaidOffAndTerminatedWithProceedsFromUtahTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "TermLoanPaidOffAndTerminatedWithProceedsFromUtahTransaction", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term loan paid off and terminated with proceeds from Utah transaction", "label": "Term Loan Paid Off And Terminated With Proceeds From Utah Transaction", "documentation": "Term Loan Paid Off And Terminated With Proceeds From Utah Transaction" } } }, "auth_ref": [] }, "mpw_TermLoanReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "TermLoanReceivable", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Term loan receivable.", "label": "Term Loan Receivable", "terseLabel": "Term loan" } } }, "auth_ref": [] }, "mpw_TexasAndMassachusettsMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "TexasAndMassachusettsMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesDevelopmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "TEXAS And MASSACHUSETTS [Member]", "documentation": "TEXAS And MASSACHUSETTS." } } }, "auth_ref": [] }, "mpw_ThreePointFiveZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandThirtyOneMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "ThreePointFiveZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandThirtyOneMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Three point five zero zero percentage senior unsecured notes due two thousand thirty one.", "label": "Three Point Five Zero Zero Percentage Senior Unsecured Notes Due Two Thousand Thirty One [Member]", "terseLabel": "3.500% Senior Unsecured Notes due 2031 [Member]" } } }, "auth_ref": [] }, "mpw_ThreePointSixNineTwoPercentageSeniorUnsecuredNotesDueTwoThousandTwentyEightMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "ThreePointSixNineTwoPercentageSeniorUnsecuredNotesDueTwoThousandTwentyEightMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Three point six nine two percentage senior unsecured notes due two thousand twenty eight.", "label": "Three Point Six Nine Two Percentage Senior Unsecured Notes Due Two Thousand Twenty Eight [Member]", "terseLabel": "3.692% Senior Unsecured Notes due 2028 [Member]" } } }, "auth_ref": [] }, "mpw_ThreePointThreeSevenFivePercentageSeniorUnsecuredNotesDueTwoThousandThirtyMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "ThreePointThreeSevenFivePercentageSeniorUnsecuredNotesDueTwoThousandThirtyMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Three point three seven five percentage senior unsecured notes due two thousand thirty.", "label": "Three Point Three Seven Five Percentage Senior Unsecured Notes Due Two Thousand Thirty [Member]", "terseLabel": "3.375% Senior Unsecured Notes due 2030 [Member]" } } }, "auth_ref": [] }, "mpw_ThreePointThreeTwoFivePercentageSeniorUnsecuredNotesDueTwoThousandTwentyFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "ThreePointThreeTwoFivePercentageSeniorUnsecuredNotesDueTwoThousandTwentyFiveMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "terseLabel": "3.325% Senior Unsecured Notes due 2025 [Member]", "documentation": "Three point three two five percentage senior unsecured notes due two thousand twenty five.", "label": "Three Point Three Two Five Percentage Senior Unsecured Notes Due Two Thousand Twenty Five [Member]" } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount", "terseLabel": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r808" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]", "terseLabel": "Total Shareholder Return Vs Peer Group" } } }, "auth_ref": [ "r815" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]", "terseLabel": "Trading Arrangement:" } } }, "auth_ref": [ "r835" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]", "terseLabel": "Trading Arrangements, by Individual" } } }, "auth_ref": [ "r837" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherInvestmentActivitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Financial Instruments [Domain]", "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r371", "r376", "r458", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r573", "r851", "r852", "r853", "r854", "r855", "r856", "r857", "r886", "r887", "r888", "r889" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Adoption Date", "terseLabel": "Adoption Date" } } }, "auth_ref": [ "r838" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Duration", "terseLabel": "Arrangement Duration" } } }, "auth_ref": [ "r839" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r837" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Title", "terseLabel": "Title" } } }, "auth_ref": [ "r837" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Securities Aggregate Available Amount", "terseLabel": "Aggregate Available" } } }, "auth_ref": [ "r840" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Termination Date", "terseLabel": "Termination Date" } } }, "auth_ref": [ "r838" ] }, "mpw_TwoPointFiveFiveZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentyThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "TwoPointFiveFiveZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentyThreeMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureDebt2023ActivityAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Two point five five zero percentage senior unsecured notes due two thousand twenty three.", "label": "Two Point Five Five Zero Percentage Senior Unsecured Notes Due Two Thousand Twenty Three [Member]", "terseLabel": "2.550% Senior Unsecured Notes due 2023 [Member]" } } }, "auth_ref": [] }, "mpw_TwoPointFiveZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "TwoPointFiveZeroZeroPercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Two point five zero zero percentage senior unsecured notes due two thousand twenty six.", "label": "Two Point Five Zero Zero Percentage Senior Unsecured Notes Due Two Thousand Twenty Six [Member]", "terseLabel": "2.500% Senior Unsecured Notes due 2026 [Member]" } } }, "auth_ref": [] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfArrangementAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r443" ] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "US", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Total U.S. [Member]", "label": "UNITED STATES", "terseLabel": "U.S. [Member]" } } }, "auth_ref": [] }, "stpr_UT": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2023", "localname": "UT", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesScheduleOfConcentrationsOfCreditRiskDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Utah [Member]", "label": "UTAH" } } }, "auth_ref": [] }, "mpw_UnbilledRentAccruals": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "UnbilledRentAccruals", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Unbilled rent accruals", "label": "Unbilled Rent Accruals", "documentation": "Unbilled rent accruals." } } }, "auth_ref": [] }, "mpw_UndistributedEarningAllocatedToParticipatingSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "UndistributedEarningAllocatedToParticipatingSecurities", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail" ], "lang": { "en-us": { "role": { "documentation": "Undistributed earning allocated to participating securities.", "label": "Undistributed Earning Allocated To Participating Securities", "negatedLabel": "Participating securities\u2019 share in earnings" } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent", "terseLabel": "Underlying Security Market Price Change" } } }, "auth_ref": [ "r834" ] }, "mpw_UnfavorableFairMarketValueAdjustmentOnInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "UnfavorableFairMarketValueAdjustmentOnInvestment", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Unfavorable fair market value adjustment on investment", "label": "Unfavorable Fair Market Value Adjustment On Investment", "documentation": "Unfavorable Fair Market Value Adjustment On Investment" } } }, "auth_ref": [] }, "mpw_UnfavorableNonCashFairValueAdjustmentOnInvestment": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "UnfavorableNonCashFairValueAdjustmentOnInvestment", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Unfavorable non-cash fair value adjustment on investment.", "label": "Unfavorable Non Cash Fair Value Adjustment On Investment", "terseLabel": "Unfavorable non-cash fair value adjustment on investment" } } }, "auth_ref": [] }, "mpw_UnpaidRentAndInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "UnpaidRentAndInterest", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivities2023ActivityAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Unpaid rent and interest", "label": "Unpaid Rent and Interest", "documentation": "Unpaid rent and interest." } } }, "auth_ref": [] }, "mpw_UnpaidRentOrInterestReceivablesAndStraightLineRentReceivablesReserved": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "UnpaidRentOrInterestReceivablesAndStraightLineRentReceivablesReserved", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherUpdatesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unpaid rent or interest receivables and straight-line rent receivables reserved", "label": "Unpaid rent or Interest Receivables and Straight-Line Rent Receivables Reserved", "documentation": "Unpaid rent or interest receivables and straight-line rent receivables reserved." } } }, "auth_ref": [] }, "us-gaap_UnusualRiskOrUncertaintyByNatureAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnusualRiskOrUncertaintyByNatureAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Unusual Risk or Uncertainty, Nature [Axis]", "terseLabel": "Unusual Risk or Uncertainty, Nature", "documentation": "Information by nature of risk and uncertainty, for example, but not limited to, threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost." } } }, "auth_ref": [] }, "us-gaap_UnusualRiskOrUncertaintyNatureDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnusualRiskOrUncertaintyNatureDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesInvestmentsInUnconsolidatedOperatingEntitiesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Unusual Risk or Uncertainty, Nature [Domain]", "terseLabel": "Unusual Risk or Uncertainty, Nature", "documentation": "Describes the nature of the unusual risk or uncertainty, such as the threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost." } } }, "auth_ref": [] }, "us-gaap_VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestDifferenceBetweenCarryingAmountAndMaximumExposure", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Carrying Amount", "label": "Variable Interest Entity, Nonconsolidated, Comparison of Carrying Amount of Assets and Liabilities to Maximum Loss Exposure", "totalLabel": "Variable Interest Entity, Nonconsolidated, Comparison of Carrying Amount of Assets and Liabilities to Maximum Loss Exposure, Total", "documentation": "Difference between the carrying amount of assets and liabilities in the reporting entity's statement of financial position that relate to the reporting entity's variable interest in the variable interest entity (VIE) and the reporting entity's maximum exposure to loss as a result of its involvement with the VIE, where the reporting entity is not the VIE's primary beneficiary." } } }, "auth_ref": [ "r76" ] }, "us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityEntityMaximumLossExposureAmount", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum Loss Exposure", "label": "Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount", "documentation": "The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE)." } } }, "auth_ref": [ "r78", "r82" ] }, "mpw_VariableInterestEntityEquityInvestmentsMaximumLossExposureAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "VariableInterestEntityEquityInvestmentsMaximumLossExposureAmount", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Investments", "label": "Variable Interest Entity Equity Investments Maximum Loss Exposure Amount", "documentation": "Variable interest entity equity investments maximum loss exposure amount." } } }, "auth_ref": [] }, "us-gaap_VariableInterestEntityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityLineItems", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "label": "Variable Interest Entity [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r445", "r446", "r449", "r450", "r515", "r516", "r517" ] }, "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "label": "Variable Interest Entity, Not Primary Beneficiary [Member]", "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity." } } }, "auth_ref": [] }, "mpw_VariableInterestEquityInvestmentsCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "VariableInterestEquityInvestmentsCarryingAmount", "crdr": "debit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfCarryingValueAndClassificationOfTheAssetsAndMaximumExposureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Investments Carrying Amount", "label": "Variable Interest Equity Investments Carrying Amount.", "documentation": "Variable interest equity investments carrying amount." } } }, "auth_ref": [] }, "us-gaap_VariableRateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateAxis", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDlomBySensitivityAnalysisByUsingBasisPointVariationsDetails" ], "lang": { "en-us": { "role": { "label": "Variable Rate [Axis]", "documentation": "Information by type of variable rate." } } }, "auth_ref": [] }, "us-gaap_VariableRateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateDomain", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsScheduleOfEffectsOfMovementInDlomBySensitivityAnalysisByUsingBasisPointVariationsDetails" ], "lang": { "en-us": { "role": { "label": "Variable Rate [Domain]", "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index." } } }, "auth_ref": [] }, "mpw_VibraHealthcareLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "VibraHealthcareLLCMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesOtherUpdatesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Vibra Healthcare L L C [Member]", "documentation": "Vibra Healthcare, LLC.", "terseLabel": "Vibra Healthcare LLC [Member]" } } }, "auth_ref": [] }, "mpw_WaivePercentageCapOnUnencumberedAsset": { "xbrltype": "percentItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "WaivePercentageCapOnUnencumberedAsset", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Waive percentage cap on unencumbered asset", "label": "Waive Percentage Cap On Unencumbered Asset", "documentation": "Waive Percentage Cap On Unencumbered Asset" } } }, "auth_ref": [] }, "mpw_WaterlandPrivateEquityFundVIICVMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "WaterlandPrivateEquityFundVIICVMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Waterland Private Equity Fund VII C.V.", "label": "Waterland Private Equity Fund V I I C V [Member]", "terseLabel": "Waterland Private Equity Fund VII C.V. [Member]", "verboseLabel": "Waterland Private Equity Fund VII C.V. [Member]" } } }, "auth_ref": [] }, "mpw_WatsonvilleCommunityHospitalMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "WatsonvilleCommunityHospitalMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesCreditLossReservesAdditionalInformationDetails", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "documentation": "Watsonville community hospital.", "label": "Watsonville Community Hospital [Member]", "terseLabel": "Watsonville Community Hospital [Member]" } } }, "auth_ref": [] }, "srt_WeightedAverageMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "WeightedAverageMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "label": "Weighted Average [Member]", "documentation": "Average of a range of values, calculated with consideration of proportional relevance." } } }, "auth_ref": [ "r715", "r716", "r917", "r919", "r922" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted average shares (units) outstanding diluted", "totalLabel": "Diluted weighted-average common shares", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r249", "r258" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureEarningsPerShareUnitCalculationOfEarningsPerShareDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfNetIncomeUnaudited" ], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted average shares (units) outstanding basic", "verboseLabel": "Basic weighted-average common shares", "totalLabel": "Weighted Average Number of Shares Outstanding, Basic, Total", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r248", "r258" ] }, "mpw_WorkingCapitalAndOtherSecuredLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "WorkingCapitalAndOtherSecuredLoans", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail" ], "lang": { "en-us": { "role": { "terseLabel": "Working capital and other secured loans", "label": "Working Capital and Other Secured Loans", "documentation": "Working capital and other secured loans." } } }, "auth_ref": [] }, "mpw_WorkingCapitalAndOtherSecuredLoansTotaling": { "xbrltype": "monetaryItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "WorkingCapitalAndOtherSecuredLoansTotaling", "crdr": "credit", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/DisclosureRealEstateAndOtherActivitiesStewardHealthCareSystemAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Working capital and other secured loans totaling", "label": "Working Capital And Other Secured Loans Totaling", "documentation": "Working Capital And Other Secured Loans Totaling" } } }, "auth_ref": [] }, "mpw_ZeroPointNineNineThreePercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember": { "xbrltype": "domainItemType", "nsuri": "http://medicalpropertiestrust.com/20240331", "localname": "ZeroPointNineNineThreePercentageSeniorUnsecuredNotesDueTwoThousandTwentySixMember", "presentation": [ "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtDetail", "http://medicalpropertiestrust.com/20240331/taxonomy/role/Role_DisclosureDebtSummaryOfDebtParentheticalDetail" ], "lang": { "en-us": { "role": { "documentation": "Zero point nine nine three percentage senior unsecured notes due two thousand twenty six.", "label": "Zero Point Nine Nine Three Percentage Senior Unsecured Notes Due Two Thousand Twenty Six [Member]", "terseLabel": "0.993% Senior Unsecured Notes due 2026 [Member]" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "7", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "8", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a-c)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-16" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "470", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11B", "Subparagraph": "(c)(1)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11B", "Subparagraph": "(c)(2)", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(2)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.3,4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "25", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "310", "SubTopic": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//310-10/tableOfContent" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "320", "Publisher": "FASB", "URI": "https://asc.fasb.org//320/tableOfContent" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB TOPIC 4.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-5" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "55", "Paragraph": "37", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "2AA", "Subparagraph": "a", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-2AA" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Subparagraph": "b", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-6" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-6" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-9" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "55", "Paragraph": "182", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15(1),(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(c),9(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 4.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-5" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-23" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(13)(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.11)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.14(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r158": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r159": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "970", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//970/tableOfContent" }, "r160": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "972", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//972/tableOfContent" }, "r161": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "974", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//974/tableOfContent" }, "r162": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "976", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//976/tableOfContent" }, "r163": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "978", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//978/tableOfContent" }, "r164": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481178/840-20-25-1" }, "r165": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481178/840-20-25-2" }, "r166": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481123/840-20-35-2" }, "r167": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "840", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-4" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "SubTopic": "360", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479638/944-360-45-3" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "SubTopic": "360", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479638/944-360-45-4" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "360", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479607/944-360-50-1" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "SubTopic": "10", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-7A" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(2))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1405", "Paragraph": "(a)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1405", "Paragraph": "(a)", "Subparagraph": "(3)", "Publisher": "SEC" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1405", "Paragraph": "(c)", "Publisher": "SEC" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1405", "Paragraph": "c", "Publisher": "SEC" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Footnote": "2", "Publisher": "SEC" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Footnote": "4", "Publisher": "SEC" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column B", "Publisher": "SEC" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column C", "Publisher": "SEC" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column D", "Publisher": "SEC" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column E", "Publisher": "SEC" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column F", "Publisher": "SEC" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column G", "Publisher": "SEC" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column H", "Publisher": "SEC" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column I", "Publisher": "SEC" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Footnote": "4", "Publisher": "SEC" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "4", "Subsection": "08", "Paragraph": "(m)", "Subparagraph": "(1)(iii)", "Publisher": "SEC" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-17A" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-21D" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482964/270-10-50-6A" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479402/808-10-50-1" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-5A" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-9" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-3" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "40", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481724/830-30-40-1" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-12" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479016/842-30-45-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-3" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-5" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-5" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-6" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-7" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(4)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(h))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(3)(d)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-3" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 8)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "19", "Subparagraph": "(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-19" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 11)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5D", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5D", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5D" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 5)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r717": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r718": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r719": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-16" }, "r720": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-21" }, "r721": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r722": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r723": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r724": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r725": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r726": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r727": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r728": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479294/326-20-55-12" }, "r729": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8" }, "r730": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r731": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r732": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r733": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r734": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r735": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r736": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r737": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r738": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r739": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r740": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r741": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r742": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r743": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r744": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r745": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r746": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r747": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r748": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r749": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r750": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A" }, "r751": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r752": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r753": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r754": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r755": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r756": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r757": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r758": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r759": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r760": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r761": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r762": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SX 210.12-15(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-7" }, "r763": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "405", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480191/946-405-45-2" }, "r764": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r765": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r766": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r767": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r768": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r769": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r770": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r771": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r772": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r773": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r774": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r775": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r776": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r777": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r778": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r779": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r780": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r781": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r782": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r783": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r784": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r785": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r786": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r787": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r788": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r789": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r790": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r791": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r792": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r793": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r794": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r795": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r796": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r797": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r798": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r799": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r800": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r801": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r802": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r803": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r804": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r805": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r806": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r807": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r808": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r809": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r810": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r811": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r812": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r813": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r814": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r815": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r816": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r817": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r818": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r819": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r820": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r821": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r822": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r823": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r824": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r825": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r826": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r827": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r828": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r829": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r830": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r831": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r832": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r833": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r834": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r835": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r836": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r837": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r838": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r839": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r840": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r841": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r842": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r843": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r844": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-10" }, "r845": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-3" }, "r846": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r847": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r848": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r849": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r850": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r851": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r852": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(1)", "Publisher": "SEC" }, "r853": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(2)", "Publisher": "SEC" }, "r854": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(b)", "Subparagraph": "(3)", "Publisher": "SEC" }, "r855": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r856": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r857": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(c)", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r858": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "11", "Subsection": "03", "Publisher": "SEC" }, "r859": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r860": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "(a)", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r861": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "(a)", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r862": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483504/205-10-50-1" }, "r863": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r864": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r865": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r866": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(b)(7)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r867": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(b)(9)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r868": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r869": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r870": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r871": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r872": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r873": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r874": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r875": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r876": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(S-X 210.12-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r877": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r878": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r879": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r880": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r881": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r882": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r883": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3" }, "r884": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5" }, "r885": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B" }, "r886": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r887": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r888": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r889": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r890": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-4" }, "r891": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r892": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r893": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r894": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2" }, "r895": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r896": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r897": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r898": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r899": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r900": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r901": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r902": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r903": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r904": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r905": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r906": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r907": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r908": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r909": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r910": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r911": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479341/842-30-25-11" }, "r912": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-3" }, "r913": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r914": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r915": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r916": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r917": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r918": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r919": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r920": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r921": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r922": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r923": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r924": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(7)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r925": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(14)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r926": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r927": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r928": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r929": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r930": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r931": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r932": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r933": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r934": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r935": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r936": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r937": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r938": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r939": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r940": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r941": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r942": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" } } }